QUARTERLY REPORT

Q1 2025 — Quarterly report on Form 10-Q

Q1 2025PDF · 69 pages3.5 MB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 28, 2025
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number 001-02217
COCA COLA CO
(Exact name of Registrant as specified in its charter)
Delaware 	58-0628465
(State or other jurisdiction of incorporation or organization) 	(I.R.S. Employer Identification No.)
One Coca-Cola Plaza
Atlanta Georgia 	30313
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code: (404) 676-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $0.25 Par Value 	KO 	New York Stock Exchange
1.875% Notes Due 2026 	KO26 	New York Stock Exchange
0.750% Notes Due 2026 	KO26C 	New York Stock Exchange
1.125% Notes Due 2027 	KO27 	New York Stock Exchange
0.125% Notes Due 2029 	KO29A 	New York Stock Exchange
0.125% Notes Due 2029 	KO29B 	New York Stock Exchange
0.400% Notes Due 2030 	KO30B 	New York Stock Exchange
1.250% Notes Due 2031 	KO31 	New York Stock Exchange
3.125% Notes Due 2032 	KO32 	New York Stock Exchange
0.375% Notes Due 2033 	KO33 	New York Stock Exchange
0.500% Notes Due 2033 	KO33A 	New York Stock Exchange
1.625% Notes Due 2035 	KO35 	New York Stock Exchange
1.100% Notes Due 2036 	KO36 	New York Stock Exchange
0.950% Notes Due 2036 	KO36A 	New York Stock Exchange
3.375% Notes Due 2037 	KO37 	New York Stock Exchange
0.800% Notes Due 2040 	KO40B 	New York Stock Exchange
1.000% Notes Due 2041 	KO41 	New York Stock Exchange
3.500% Notes Due 2044 	KO44 	New York Stock Exchange
3.750% Notes Due 2053 	KO53 	New York Stock Exchange

-- 1 of 69 --

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 	☐
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
Class of Common Stock 	Shares Outstanding as of April 29, 2025
$0.25 Par Value 	4,304,266,738

-- 2 of 69 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
Page
Forward-Looking Statements 	1
Part I. Financial Information
Item 1. 	Financial Statements 	2
Consolidated Statements of Income — Three Months Ended March 28, 2025 and March 29, 2024 	2
Consolidated Statements of Comprehensive Income — Three Months Ended March 28, 2025 and
March 29, 2024 	3
Consolidated Balance Sheets — March 28, 2025 and December 31, 2024 	4
Consolidated Statements of Cash Flows — Three Months Ended March 28, 2025 and March 29, 2024 	5
Notes to Consolidated Financial Statements 	6
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	28
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	40
Item 4. 	Controls and Procedures 	40
Part II. Other Information
Item 1. 	Legal Proceedings 	41
Item 1A. 	Risk Factors 	43
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	43
Item 5. 	Other Information 43
Item 6. 	Exhibits 	43
Signatures 	47

-- 3 of 69 --

FORWARD-LOOKING STATEMENTS
This report contains information that may constitute “forward-looking statements.” Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,”
“will” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions
does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the
future are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to
place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Our Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking
statements are subject to certain risks and uncertainties that could cause our Company’s actual results to differ materially from historical experience and our present
expectations or projections. These risks and uncertainties include, but are not limited to, the possibility that the assumptions used to calculate our estimated aggregate
incremental tax and interest liability related to the potential unfavorable outcome of the ongoing tax dispute with the United States Internal Revenue Service could significantly
change; those described in Part II, “Item 1A. Risk Factors” and elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2024; and
those described from time to time in our future reports filed with the Securities and Exchange Commission.
1

-- 4 of 69 --

Part I. Financial Information
Item 1. Financial Statements
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions except per share data)
Three Months Ended
March 28,
2025 March 29,
2024
Net Operating Revenues 	$ 	11,129 $ 	11,300
Cost of goods sold 	4,163 	4,235
Gross Profit 	6,966 	7,065
Selling, general and administrative expenses 	3,234 	3,351
Other operating charges 	73 	1,573
Operating Income 	3,659 	2,141
Interest income 	180 	246
Interest expense 	387 	382
Equity income (loss) — net 	351 	354
Other income (loss) — net 	254 	1,513
Income Before Income Taxes 	4,057 	3,872
Income taxes 	722 	687
Consolidated Net Income 	3,335 	3,185
Less: Net income (loss) attributable to noncontrolling interests 	5 	8
Net Income Attributable to Shareowners of The Coca-Cola Company 	$ 	3,330 $ 	3,177
Basic Net Income Per Share 	$ 	0.77 $ 	0.74
Diluted Net Income Per Share $ 	0.77 $ 	0.74
Average Shares Outstanding — Basic 	4,302 	4,310
Effect of dilutive securities 	11 	12
Average Shares Outstanding — Diluted 	4,313 	4,322
Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Consolidated Financial Statements.
1
1
1
2

-- 5 of 69 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
Three Months Ended
March 28,
2025 March 29,
2024
Consolidated Net Income 	$ 	3,335 $ 	3,185
Other Comprehensive Income:
Net foreign currency translation adjustments 	619 	(303)
Net gains (losses) on derivatives 	(257) 	49
Net change in unrealized gains (losses) on available-for-sale debt securities 	13 	5
Net change in pension and other postretirement benefit liabilities 	19 	(4)
Total Comprehensive Income 	3,729 	2,932
Less: Comprehensive income (loss) attributable to noncontrolling interests 	38 	(16)
Total Comprehensive Income Attributable to Shareowners of The Coca-Cola Company 	$ 	3,691 $ 	2,948
Refer to Notes to Consolidated Financial Statements.
3

-- 6 of 69 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions except par value)
March 28,
2025
December 31,
2024
ASSETS
Current Assets
Cash and cash equivalents 	$ 	8,417 $ 	10,828
Short-term investments 	3,579 	2,020
Total Cash, Cash Equivalents and Short-Term Investments 	11,996 	12,848
Marketable securities 	1,791 	1,723
Trade accounts receivable, less allowances of $509 and $506, respectively 	4,091 	3,569
Inventories 	5,102 	4,728
Prepaid expenses and other current assets 	3,198 	3,129
Total Current Assets 	26,178 	25,997
Equity method investments 	18,369 	18,087
Deferred income tax assets 	1,311 	1,319
Property, plant and equipment, less accumulated depreciation of $9,809 and $9,570, respectively 	10,431 	10,303
Trademarks with indefinite lives 	13,425 	13,301
Goodwill 	18,333 	18,139
Other noncurrent assets 	13,669 	13,403
Total Assets 	$ 	101,716 $ 	100,549
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses 	$ 	16,499 $ 	21,715
Loans and notes payable 	5,418 	1,499
Current maturities of long-term debt 	163 	648
Accrued income taxes 	1,728 	1,387
Total Current Liabilities 	23,808 	25,249
Long-term debt 	43,530 	42,375
Other noncurrent liabilities 	4,313 	4,084
Deferred income tax liabilities 	2,311 	2,469
The Coca-Cola Company Shareowners’ Equity
Common stock, $0.25 par value; authorized — 11,200 shares; issued — 7,040 shares 	1,760 	1,760
Capital surplus 	19,873 	19,801
Reinvested earnings 	77,189 	76,054
Accumulated other comprehensive income (loss) 	(16,482) 	(16,843)
Treasury stock, at cost — 2,736 and 2,738 shares, respectively 	(56,138) 	(55,916)
Equity Attributable to Shareowners of The Coca-Cola Company 	26,202 	24,856
Equity attributable to noncontrolling interests 	1,552 	1,516
Total Equity 	27,754 	26,372
Total Liabilities and Equity 	$ 	101,716 $ 	100,549
Refer to Notes to Consolidated Financial Statements.
4

-- 7 of 69 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
Three Months Ended
March 28,
2025 March 29,
2024
Operating Activities
Consolidated net income 	$ 	3,335 $ 	3,185
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization 	267 	262
Stock-based compensation expense 	63 	68
Deferred income taxes 	95 	(173)
Equity (income) loss — net of dividends 	(264) 	(58)
Foreign currency adjustments 	50 	17
Significant (gains) losses — net 	(331) 	(1,401)
Other operating charges 	— 	1,532
Other items 	104 	(59)
Net change in operating assets and liabilities 	(8,521) 	(2,845)
Net Cash Provided by (Used in) Operating Activities 	(5,202) 	528
Investing Activities
Purchases of investments 	(2,507) 	(2,552)
Proceeds from disposals of investments 	1,005 	444
Acquisitions of businesses, equity method investments and nonmarketable securities 	(42) 	(8)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 	748 	2,893
Purchases of property, plant and equipment 	(309) 	(370)
Proceeds from disposals of property, plant and equipment 	8 	14
Collateral (paid) received associated with hedging activities — net 	(15) 	(105)
Other investing activities 	45 	14
Net Cash Provided by (Used in) Investing Activities 	(1,067) 	330
Financing Activities
Issuances of loans, notes payable and long-term debt 	5,436 	2,285
Payments of loans, notes payable and long-term debt 	(1,599) 	(1,366)
Issuances of stock 	159 	290
Purchases of stock for treasury 	(370) 	(702)
Dividends 	(89) 	(99)
Other financing activities 	(105) 	(2)
Net Cash Provided by (Used in) Financing Activities 	3,432 	406
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 	163 	(138)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents during the period 	(2,674) 	1,126
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 	11,488 	9,692
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period 	8,814 	10,818
Less: Restricted cash and restricted cash equivalents at end of period 	397 	375
Cash and Cash Equivalents at End of Period 	$ 	8,417 $ 	10,443
Refer to Notes to Consolidated Financial Statements.
5

-- 8 of 69 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S.
GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by
U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated
Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2024.
When used in these notes, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included.
Operating results for the three months ended March 28, 2025 are not necessarily indicative of the results that may be expected for the year ending December 31, 2025. Sales of
our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of sales in the
beverage business may be affected by weather conditions.
Each of our quarterly reporting periods, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The first quarter
of 2025 and the first quarter of 2024 ended on March 28, 2025 and March 29, 2024, respectively. Our fourth quarter and our fiscal year end on December 31 regardless of the
day of the week on which December 31 falls.
Advertising Costs
The Company’s accounting policy related to advertising costs for annual reporting purposes is to expense production costs of print, radio, television and other advertisements as
of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.
For quarterly reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple quarters to each of those quarters. We use the proportion of
each quarter’s actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being
recognized at a standard rate per unit case. At the end of each quarter, we review our estimated full year unit case volume and our estimated full year marketing expenditures
that benefit multiple quarters in order to evaluate if a change in estimate is necessary. The impact of any change in the full year estimate is recognized in the quarter in which
the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents or restricted cash
equivalents, as applicable. Restricted cash and restricted cash equivalents generally consist of amounts held by our captive insurance companies, which are included in the line
item other noncurrent assets in our consolidated balance sheet, and when applicable, cash and cash equivalents related to assets held for sale are included in the line item
prepaid expenses and other current assets in our consolidated balance sheet. We manage our exposure to counterparty credit risk through specific minimum credit standards,
diversification of counterparties and procedures to monitor our concentrations of credit risk. Refer to Note 2 for additional information on our assets held for sale and Note 4 for
additional information on our captive insurance companies.
The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated
statements of cash flows (in millions):
March 28,
2025
December 31,
2024
Cash and cash equivalents 	$ 	8,417 $ 	10,828
Restricted cash and restricted cash equivalents 	397 	660
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	8,814 $ 	11,488
6

-- 9 of 69 --

March 29,
2024
December 31,
2023
Cash and cash equivalents 	$ 	10,443 $ 	9,366
Restricted cash and restricted cash equivalents 	375 	326
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	10,818 $ 	9,692
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $42 million during the three months ended March 28, 2025, which
included $30 million of investments in alternative energy limited partnerships. Refer to Note 15 for additional information on these investments. Our Company’s acquisitions of
businesses, equity method investments and nonmarketable securities totaled $8 million during the three months ended March 29, 2024.
Divestitures
Proceeds from disposals of businesses, equity method investments and nonmarketable securities during the three months ended March 28, 2025 totaled $748 million, which
primarily related to the sale of a portion of our ownership interest in Coca-Cola Europacific Partners plc, an equity method investee (“CCEP”), for which we received cash
proceeds of $741 million and recognized a net gain of $331 million.
Proceeds from disposals of businesses, equity method investments and nonmarketable securities during the three months ended March 29, 2024 totaled $2,893 million. The
Company refranchised its bottling operations in certain territories in India in January and February 2024, for which we received net cash proceeds of $476 million and
recognized a net gain of $293 million. The Company refranchised its bottling operations in Bangladesh to Coca-Cola İçecek A.Ş., an equity method investee, in February 2024,
for which we received net cash proceeds of $27 million and a note receivable of $29 million and recognized a net loss of $18 million, primarily due to the related reversal of
cumulative translation adjustments. During the three months ended March 28, 2025, the Company recognized an additional loss of $14 million related to post-closing
adjustments and a corresponding reduction in the outstanding note receivable balance. Additionally, in February 2024, the Company refranchised its bottling operations in the
Philippines to CCEP and a local business partner, for which we received net cash proceeds of $1,656 million and recognized a net gain of $599 million. We also sold our
ownership interest in an equity method investee in Thailand, for which we received net cash proceeds of $728 million and recognized a net gain of $516 million.
These gains and losses were recorded in the line item other income (loss) — net in our consolidated statements of income.
Assets and Liabilities Held for Sale
As of March 28, 2025 and December 31, 2024, the Company’s bottling operations in certain territories in India met the criteria to be classified as held for sale. As a result, we
were required to record the related assets and liabilities at the lower of carrying value or fair value less any costs to sell. As the fair values less any costs to sell exceeded the
carrying values, the related assets and liabilities were recorded at their carrying values. These assets and liabilities were included in the Bottling Investments operating segment.
The following table presents information related to the major classes of assets and liabilities that were classified as held for sale and were included in the line items prepaid
expenses and other current assets and accounts payable and accrued expenses, respectively, in our consolidated balance sheet (in millions):
March 28,
2025 	December 31, 2024
Inventories 	$ 	12 $ 	23
Property, plant and equipment — net 	107 	108
Assets held for sale 	$ 	119 $ 	131
Accounts payable and accrued expenses 	$ 	2 $ 	2
Other noncurrent liabilities 	— 	1
Liabilities held for sale 	$ 	2 $ 	3
7

-- 10 of 69 --

NOTE 3: NET OPERATING REVENUES
The following table presents net operating revenues disaggregated between the United States and International and further by line of business (in millions):
United States 	International 	Total
Three Months Ended March 28, 2025
Concentrate operations 	$ 	1,927 $ 	5,256 $ 	7,183
Finished product operations 	2,326 	1,620 	3,946
Total 	$ 	4,253 $ 	6,876 $ 	11,129
Three Months Ended March 29, 2024
Concentrate operations 	$ 	2,125 $ 	4,530 $ 	6,655
Finished product operations 	1,993 	2,652 	4,645
Total 	$ 	4,118 $ 	7,182 $ 	11,300
Refer to Note 17 for disclosures of net operating revenues by operating segment and Corporate.
NOTE 4: INVESTMENTS
Equity Securities
The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions):
Fair Value with Changes
Recognized in Income
Measurement Alternative
— No Readily
Determinable Fair Value
March 28, 2025
Marketable securities 	$ 	405 $ 	—
Other noncurrent assets 	1,651 	42
Total equity securities 	$ 	2,056 $ 	42
December 31, 2024
Marketable securities 	$ 	418 $ 	—
Other noncurrent assets 	1,616 	40
Total equity securities 	$ 	2,034 $ 	40
The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions):
Three Months Ended
March 28,
2025
March 29,
2024
Net gains (losses) recognized during the period related to equity securities 	$ 	(15) $ 	183
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 	8 	49
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period 	$ 	(23) $ 	134
8

-- 11 of 69 --

Debt Securities
Our debt securities consisted of the following (in millions):
Gross Unrealized 	Estimated
Fair Value	Cost 	Gains 	Losses
March 28, 2025
Trading securities $ 	47 $ 	1 $ 	— $ 	48
Available-for-sale securities 1,795 	21 	(101) 	1,715
Total debt securities $ 	1,842 $ 	22 $ 	(101) $ 	1,763
December 31, 2024
Trading securities $ 	45 $ 	1 $ 	(1) $ 	45
Available-for-sale securities 1,728 	21 	(118) 	1,631
Total debt securities $ 	1,773 $ 	22 $ 	(119) $ 	1,676
The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions):
March 28, 2025 	December 31, 2024
Trading Securities
Available-for-Sale
Securities 	Trading Securities
Available-for-Sale
Securities
Marketable securities $ 	48 $ 	1,338 	$ 	45 $ 	1,260
Other noncurrent assets — 	377 	— 	371
Total debt securities 	$ 	48 $ 	1,715 	$ 	45 $ 	1,631
The contractual maturities of these available-for-sale debt securities as of March 28, 2025 were as follows (in millions):
Cost
Estimated
Fair Value
Within 1 year 	$ 	333 $ 	331
After 1 year through 5 years 	1,245 	1,174
After 5 years through 10 years 	38 	45
After 10 years 	179 	165
Total 	$ 	1,795 $ 	1,715
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):
Three Months Ended
March 28,
2025 March 29,
2024
Gross gains 	$ 	1 $ 	1
Gross losses 	(2) 	(7)
Proceeds 	137 	383
Captive Insurance Companies
In accordance with local insurance regulations, our consolidated captive insurance companies are required to meet and maintain minimum solvency capital requirements. The
Company elected to invest a majority of its solvency capital in a portfolio of marketable equity and debt securities. These securities are included in the disclosures above. The
Company uses one of our consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the obligations of certain of our European and
Canadian pension plans. This captive’s solvency capital funds included total equity and debt securities of $1,923 million and $1,883 million as of March 28, 2025 and
December 31, 2024, respectively, which were classified in the line item other noncurrent assets in our consolidated balance sheets because the assets were not available to
satisfy our current obligations.
9

-- 12 of 69 --

NOTE 5: INVENTORIES
Inventories consisted of the following (in millions):
March 28,
2025
December 31,
2024
Raw materials and packaging 	$ 	3,044 $ 	2,794
Finished goods 	1,641 	1,524
Other 	417 	410
Total inventories 	$ 	5,102 $ 	4,728
NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the fair values of the Company’s derivative instruments that were designated and qualified as part of a hedging relationship (in millions):
Fair Value
Derivatives Designated as Hedging Instruments 	Financial Statement Line Item Impacted
March 28,
2025
December 31,
2024
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	99 $ 	311
Foreign currency contracts 	Other noncurrent assets 	32 	82
Commodity contracts 	Prepaid expenses and other current assets 	3 	2
Interest rate contracts 	Other noncurrent assets 	45 	27
Total assets 	$ 	179 $ 	422
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	41 $ 	14
Foreign currency contracts 	Other noncurrent liabilities 	61 	39
Interest rate contracts 	Accounts payable and accrued expenses 	1 	—
Interest rate contracts 	Other noncurrent liabilities 	859 	922
Total liabilities 	$ 	962 $ 	975
All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash
collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master
netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company’s derivative instruments.
Refer to Note 16 for additional information related to the estimated fair value.
1,2
1
1
2
10

-- 13 of 69 --

The following table presents the fair values of the Company’s derivative instruments that were not designated as hedging instruments (in millions):
Fair Value
Derivatives Not Designated as Hedging Instruments 	Financial Statement Line Item Impacted
March 28,
2025 	December 31, 2024
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	58 $ 	152
Foreign currency contracts 	Other noncurrent assets 	12 	8
Commodity contracts 	Prepaid expenses and other current assets 	6 	7
Other derivative instruments 	Prepaid expenses and other current assets 	7 	—
Total assets 	$ 	83 $ 	167
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	90 $ 	86
Foreign currency contracts 	Other noncurrent liabilities 	4 	12
Commodity contracts 	Accounts payable and accrued expenses 	32 	40
Other derivative instruments 	Accounts payable and accrued expenses 	— 	6
Total liabilities 	$ 	126 $ 	144
All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash
collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master
netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company’s derivative instruments.
Refer to Note 16 for additional information related to the estimated fair value.
Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty
exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring
collateral for substantially all of our transactions. To mitigate pre-settlement risk, minimum credit standards become more stringent as the duration of the derivative financial
instrument increases. In addition, the Company’s master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same
counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Furthermore, for certain derivative
financial instruments, the Company has agreements with counterparties that require collateral to be exchanged based on changes in the fair value of the instruments. The
Company classifies collateral payments and receipts as investing cash flows when the collateral account is in an asset position and as financing cash flows when the collateral
account is in a liability position. As a result of these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency
exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in accumulated other
comprehensive income (loss) (“AOCI”) and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same
period the hedged items affect earnings. The changes in the fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings.
The maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our U.S. dollar net cash inflows from sales outside the United States and U.S.
dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase
foreign currency options and collars (principally euro, British pound and Japanese yen) to hedge certain portions of forecasted cash flows denominated in foreign currencies.
When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value
of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in
the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualified for the Company’s foreign currency cash flow hedging
program were $11,971 million and $9,206 million as of March 28, 2025 and December 31, 2024, respectively.
1,2
1
1
2
11

-- 14 of 69 --

The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt and other monetary assets or liabilities due to
fluctuations in foreign currency exchange rates. For this hedging program, the Company recognizes in earnings each period the changes in carrying values of these foreign
currency denominated assets and liabilities due to fluctuations in exchange rates. The changes in fair values of the cross-currency swap derivatives are recorded in AOCI with
an immediate reclassification into earnings for the changes in fair values attributable to fluctuations in foreign currency exchange rates. The total notional value of derivatives
that were designated as cash flow hedges for the Company’s foreign currency denominated assets and liabilities was $557 million as of both March 28, 2025 and December 31,
2024.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted
purchases of materials used in our manufacturing process. These derivative instruments were designated as part of the Company’s commodity cash flow hedging program. The
objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional values of derivatives that
were designated and qualified for this program were $87 million and $58 million as of March 28, 2025 and December 31, 2024, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. We manage our risk related to interest rate fluctuations through the use of derivative financial
instruments. From time to time, the Company has entered into interest rate swap agreements and has designated these instruments as part of the Company’s interest rate cash
flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company’s future interest payments.
The total notional value of derivatives that were designated and qualified for this program was $1,000 million as of March 28, 2025. There were no derivatives that were
designated as part of the Company’s interest rate cash flow hedging program as of December 31, 2024.
The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on other comprehensive income (“OCI”), AOCI
and earnings (in millions):
Gain (Loss)
Recognized
in OCI Financial Statement Line Item Impacted Gain (Loss) Reclassified
from AOCI into Income
Three Months Ended March 28, 2025
Foreign currency contracts 	$ 	(269) Net operating revenues 	$ 	41
Foreign currency contracts 	(7) Cost of goods sold 	3
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	(4) Other income (loss) — net 	24
Commodity contracts 	3 Cost of goods sold 	3
Interest rate contracts 	— Interest expense 	(1)
Total 	$ 	(277) 	$ 	69
Three Months Ended March 29, 2024
Foreign currency contracts 	$ 	48 Net operating revenues 	$ 	(17)
Foreign currency contracts 	11 Cost of goods sold 	3
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	(15) Other income (loss) — net 	(28)
Commodity contracts 	1 Cost of goods sold 	(1)
Interest rate contracts 	1 Interest expense 	—
Total 	$ 	46 	$ 	(44)
As of March 28, 2025, the Company estimates that it will reclassify into earnings during the next 12 months net gains of $4 million from the pretax amount recorded in AOCI
as the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that result from
fluctuations in benchmark interest rates. The Company also uses cross-currency interest rate swaps to hedge the changes in the fair value of foreign currency denominated debt
relating to fluctuations in foreign currency exchange rates and benchmark interest rates. The changes in the fair values of derivatives designated as fair value hedges and the
offsetting changes in the fair values of the hedged items are recognized in earnings. As a result, any difference is reflected in earnings as ineffectiveness. When a derivative is
no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged
item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately
12

-- 15 of 69 --

if the hedged item has matured or has been extinguished. The total notional values of derivatives that were designated and qualified as fair value hedges of this type were
$12,984 million and $12,628 million as of March 28, 2025 and December 31, 2024, respectively.
The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions):
Hedging Instruments and Hedged Items 	Financial Statement Line Item Impacted
Gain (Loss)
Recognized in Income
Three Months Ended
March 28,
2025
March 29,
2024
Interest rate contracts 	Interest expense 	$ 	80 $ 	(145)
Fixed-rate debt 	Interest expense 	(76) 	147
Net impact of fair value hedging instruments 	$ 	4 $ 	2
The following table summarizes the amounts recorded in our consolidated balance sheets related to hedged items in fair value hedging relationships (in millions):
Cumulative Amount of Fair Value Hedging Adjustments
Carrying Values of
Hedged Items
Included in the Carrying Values of Hedged
Items
Remaining for Which Hedge Accounting Has
Been Discontinued
Balance Sheet Location of Hedged Items March 28,
2025 December 31,
2024 March 28,
2025 December 31,
2024 March 28,
2025 December 31,
2024
Long-term debt 	$ 	12,251 $ 	11,824 	$ 	(858) $ 	(915) 	$ 	122 $ 	130
Cumulative amount of fair value hedging adjustments does not include changes due to foreign currency exchange rate fluctuations.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial instrument, to protect the value of our net investments
in a number of foreign operations. For derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the fair
values of the derivative financial instruments are recognized in net foreign currency translation adjustments, a component of AOCI, to offset the changes in the values of the net
investments being hedged. For non-derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the
carrying values of the designated portions of the non-derivative financial instruments due to fluctuations in foreign currency exchange rates are recorded in net foreign currency
translation adjustments. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change.
The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions):
Notional Values 	Gain (Loss) Recognized in OCI
as of 	Three Months Ended
March 28,
2025
December 31,
2024
March 28,
2025
March 29,
2024
Foreign currency contracts 	$ 	— $ 	59 	$ 	(1) $ 	2
Foreign currency denominated debt 	13,826 	13,221 	(605) 	272
Total 	$ 	13,826 $ 	13,280 	$ 	(606) $ 	274
The Company reclassified a gain of $3 million related to net investment hedges from AOCI into earnings during the three months ended March 29, 2024. The Company did not
reclassify any gains or losses during the three months ended March 28, 2025. In addition, the Company did not have any ineffectiveness related to net investment hedges during
the three months ended March 28, 2025 and March 29, 2024. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment
hedges are classified in the line item other investing activities in our consolidated statement of cash flows.
1
1
13

-- 16 of 69 --

Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that have been designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign
currency, interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic
hedges. The changes in the fair values of economic hedges are immediately recognized in earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and
liabilities denominated in nonfunctional currencies. The changes in the fair values of economic hedges used to offset those monetary assets and liabilities are immediately
recognized in earnings in the line item other income (loss) — net in our consolidated statement of income. In addition, we use foreign currency economic hedges to minimize
the variability in cash flows associated with fluctuations in foreign currency exchange rates, including those related to certain acquisition and divestiture activities. The changes
in the fair values of economic hedges used to offset the variability in U.S. dollar net cash flows are immediately recognized in earnings in the line items net operating revenues,
cost of goods sold or other income (loss) — net in our consolidated statement of income, as applicable. The total notional values of derivatives related to our foreign currency
economic hedges were $9,694 million and $8,620 million as of March 28, 2025 and December 31, 2024, respectively.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and
vehicle fuel. The changes in the fair values of these economic hedges are immediately recognized in earnings in the line items net operating revenues, cost of goods sold, or
selling, general and administrative expenses in our consolidated statement of income, as applicable. The total notional values of derivatives related to our economic hedges of
this type were $619 million and $328 million as of March 28, 2025 and December 31, 2024, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions):
Derivatives Not Designated as Hedging Instruments 	Financial Statement Line Item Impacted
Gain (Loss)
Recognized in Income
Three Months Ended
March 28,
2025
March 29,
2024
Foreign currency contracts 	Net operating revenues 	$ 	(71) $ 	61
Foreign currency contracts 	Cost of goods sold 	21 	14
Foreign currency contracts 	Other income (loss) — net 	29 	38
Commodity contracts 	Cost of goods sold 	4 	(19)
Other derivative instruments 	Selling, general and administrative expenses 	1 	6
Total 	$ 	(16) $ 	100
NOTE 7: SUPPLY CHAIN FINANCE PROGRAM
Our current payment terms with the majority of our suppliers are 120 days. Certain financial institutions offer a voluntary supply chain finance (“SCF”) program, which enables
our suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions on a non-recourse basis at a rate that leverages our credit rating
and thus may be more beneficial to them. The SCF program is available to suppliers of goods and services included in cost of goods sold and selling, general and administrative
expenses in our consolidated statement of income. The Company and our suppliers agree on contractual terms for the goods and services we procure, including prices,
quantities and payment terms, regardless of whether the supplier elects to participate in the SCF program. The suppliers sell goods or services, as applicable, to the Company
and issue the associated invoices to the Company based on the agreed-upon contractual terms. Then, if they are participating in the SCF program, our suppliers sell their
invoices to the financial institutions. Our suppliers’ voluntary participation in the SCF program has no bearing on our payment terms. No guarantees are provided by the
Company or any of our subsidiaries under the SCF program. We have no economic interest in a supplier’s decision to participate in the SCF program, and we have no direct
financial relationship with the financial institutions, as it relates to the SCF program. Accordingly, amounts due to our suppliers that elected to participate in the SCF program
are included in the line item accounts payable and accrued expenses in our consolidated balance sheet. All activity related to amounts due to suppliers that elected to participate
in the SCF program is reflected within the operating activities section of our consolidated statement of cash flows. As of March 28, 2025 and December 31, 2024, the amount of
obligations outstanding that the Company has confirmed as valid to the financial institutions under the SCF program was $1,231 million and $1,330 million, respectively.
14

-- 17 of 69 --

NOTE 8: DEBT AND BORROWING ARRANGEMENTS
Loans and notes payable consist primarily of commercial paper issued in the United States. As of March 28, 2025 and December 31, 2024, we had $5,045 million and
$1,139 million, respectively, in outstanding commercial paper borrowings.
During the three months ended March 28, 2025, our bottling operations in Africa refinanced $485 million of current maturities of long-term debt into long-term debt.
NOTE 9: COMMITMENTS AND CONTINGENCIES
Guarantees
As of March 28, 2025, we were contingently liable for guarantees of indebtedness owed by third parties of $726 million, of which $56 million was related to variable interest
entities. Our guarantees are primarily related to third-party customers, bottlers and vendors and have arisen through the normal course of business. These guarantees have
various terms, and none of these guarantees is individually significant. These amounts represent the maximum potential future payments that we could be required to make
under the guarantees. However, management has concluded that the likelihood of any significant amounts being paid by our Company under these guarantees is remote.
Concentrations of Credit Risk
We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
Legal Contingencies
The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is
probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is
reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities of the Company that may arise as a result of
currently pending legal proceedings (excluding tax audit claims) will not have a material adverse effect on the Company taken as a whole.
Tax Audits
The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. These uncertain tax matters may result in the assessment of additional
taxes.
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the United States Internal Revenue Service (“IRS”) seeking approximately
$3.3 billion of additional federal income tax for years 2007 through 2009. In the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent
company from certain of its foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S.
markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in a closing agreement resolving that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances or relevant
federal tax law, in calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax calculation
methodology that the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of
15

-- 18 of 69 --

the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly imposed tax assessment and pay the full amount of the asserted tax or litigate the
matter in the federal courts. The matter remains subject to the IRS’ litigation designation, preventing the Company from any attempt to settle or otherwise mutually resolve the
matter with the IRS.
The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015, challenging the tax adjustments enumerated in the
Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid
by the foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would
become payable to the Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion (together with the original Tax Court
opinion, “Opinions”), siding with the IRS in concluding both that certain U.S. tax regulations (known as the blocked-income regulations) that address the effect of certain
Brazilian legal restrictions on royalty payments by the Company’s licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v.
Commissioner (February 9, 2023) controlled as to the validity of those regulations.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different
from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on
appeal and vigorously defend its positions. In addition, for its litigation with the IRS and for purposes of its appeal of the Tax Court decision, the Company continues to
evaluate the implications of several significant administrative law cases recently decided by the U.S. Supreme Court, most notably Loper Bright v. Raimondo, which overruled
Chevron U.S.A., Inc. v. NRDC (“Chevron case”). Since 1984, the Chevron case had required that courts defer to agency interpretations of statutes and agency action. In Ohio v.
EPA and Garland v. Cargill, two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to rule on agency interpretations and actions without the
deference previously required by the Chevron case.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid those invoices (“IRS Tax Litigation Deposit”) on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through
2009 tax years. That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three months
ended March 28, 2025, the Company recorded net interest income of $53 million related to this tax payment in the line item income taxes in our consolidated statement of
income, in accordance with our accounting policy. The payment of the IRS invoices and the related accrued interest were recorded in the line item other noncurrent assets in our
consolidated balance sheets as of March 28, 2025 and December 31, 2024. On October 22, 2024, the Company appealed the Tax Court’s decision to the U.S. Court of Appeals
for the Eleventh Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March 12, 2025.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors, and we reviewed and considered relevant laws, rules, and
regulations, including, but not limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-
founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not
the Company’s tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the
methodology asserted by the IRS and affirmed in the Opinions (“Tax Court Methodology”), that could be applied by the courts upon final resolution of the litigation. Based on
the required probability analysis, we determined the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result
of this analysis, we recorded a tax reserve of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as the
different tax treatment applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be
recharacterized as royalties in accordance with the Opinions and the Company’s analysis.
16

-- 19 of 69 --

The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of March 28, 2025. However,
based on the required probability analysis and the accrual of interest through the current reporting period, we updated our tax reserve as of March 28, 2025 to $483 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is possible that some portion or all of the
adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or
all of the $6.0 billion it paid in response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $171 million as of March 28, 2025.
Additionally, the Company would likely be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the Company’s
financial position, results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinions for the 2010 through 2024 tax years, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to
subsequent years, with consent of the federal courts. This impact would include taxes and interest accrued through December 31, 2024. The calculations incorporated the
estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the potential
aggregate remaining incremental tax and interest liability for the tax years 2010 through 2024 could be approximately $12 billion as of December 31, 2024. Additional income
tax and interest on any unpaid potential liabilities for the 2010 through 2024 tax years would continue to accrue until the time any such potential liability, or portion thereof,
were to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three months ended March 28, 2025 would increase the
potential aggregate incremental tax and interest liability by approximately $400 million. We currently project the continued application of the Tax Court Methodology in 2025,
assuming similar facts and circumstances as of December 31, 2024, would result in an incremental annual tax liability that would increase the Company’s effective tax rate by
approximately 3.5%.
Risk Management Programs
The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many
different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company’s risk of catastrophic loss. Our reserves for the
Company’s self-insured losses are estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on our claims
history. Our self-insurance reserves totaled $168 million as of both March 28, 2025 and December 31, 2024.
NOTE 10: OTHER COMPREHENSIVE INCOME
AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of shareowners’ equity, which also
includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet
as part of the line item equity attributable to noncontrolling interests.
AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):
March 28,
2025
December 31,
2024
Net foreign currency translation adjustments 	$ 	(15,024) $ 	(15,610)
Accumulated net gains (losses) on derivatives 	(141) 	116
Unrealized net gains (losses) on available-for-sale debt securities 	(51) 	(64)
Adjustments to pension and other postretirement benefit liabilities 	(1,266) 	(1,285)
Accumulated other comprehensive income (loss) 	$ 	(16,482) $ 	(16,843)
17

-- 20 of 69 --

The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):
Three Months Ended March 28, 2025
Shareowners of
The Coca-Cola Company Noncontrolling
Interests 	Total
Consolidated net income 	$ 	3,330 $ 	5 $ 	3,335
Other comprehensive income:
Net foreign currency translation adjustments 	586 	33 	619
Net gains (losses) on derivatives 	(257) 	— 	(257)
Net change in unrealized gains (losses) on available-for-sale debt securities 	13 	— 	13
Net change in pension and other postretirement benefit liabilities 	19 	— 	19
Total comprehensive income (loss) 	$ 	3,691 $ 	38 $ 	3,729
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees’ OCI (in millions):
Three Months Ended March 28, 2025 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	8 $ 	(9) $ 	(1)
Reclassification adjustments recognized in net income 	34 	(2) 	32
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	1,010 	— 	1,010
Gains (losses) on net investment hedges arising during the period 	(606) 	151 	(455)
Net foreign currency translation adjustments 	$ 	446 $ 	140 $ 	586
Derivatives:
Gains (losses) arising during the period 	$ 	(274) $ 	69 $ 	(205)
Reclassification adjustments recognized in net income 	(69) 	17 	(52)
Net gains (losses) on derivatives 	$ 	(343) $ 	86 $ 	(257)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	16 $ 	(4) $ 	12
Reclassification adjustments recognized in net income 	1 	— 	1
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	17 $ 	(4) $ 	13
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	(17) $ 	10 $ 	(7)
Reclassification adjustments recognized in net income 	33 	(7) 	26
Net change in pension and other postretirement benefit liabilities 	$ 	16 $ 	3 $ 	19
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	136 $ 	225 $ 	361
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
2
1
2
1
1
2
1
2
18

-- 21 of 69 --

Three Months Ended March 29, 2024 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	(34) $ 	(35) $ 	(69)
Reclassification adjustments recognized in net income 	103 	— 	103
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	(518) 	— 	(518)
Gains (losses) on net investment hedges arising during the period 	274 	(69) 	205
Net foreign currency translation adjustments 	$ 	(175) $ 	(104) $ 	(279)
Derivatives:
Gains (losses) arising during the period 	$ 	27 $ 	(11) $ 	16
Reclassification adjustments recognized in net income 	44 	(11) 	33
Net gains (losses) on derivatives 	$ 	71 $ 	(22) $ 	49
Available-for-sale debt securities:
Reclassification adjustments recognized in net income 	$ 	6 $ 	(1) $ 	5
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	6 $ 	(1) $ 	5
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	(13) $ 	(8) $ 	(21)
Reclassification adjustments recognized in net income 	22 	(5) 	17
Net change in pension and other postretirement benefit liabilities 	$ 	9 $ 	(13) $ 	(4)
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	(89) $ 	(140) $ 	(229)
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
1
2
1
2
19

-- 22 of 69 --

The following table presents the amounts and line items in our consolidated statement of income where adjustments reclassified from AOCI into income were recorded
(in millions):
Amount Reclassified from
AOCI
into Income
Description of AOCI Component 	Financial Statement Line Item Impacted Three Months Ended March
28, 2025
Foreign currency translation adjustments:
Divestitures 	Other income (loss) — net 	$ 	34
Income before income taxes 	34
Income taxes 	(2)
Consolidated net income 	$ 	32
Derivatives:
Foreign currency contracts 	Net operating revenues 	$ 	(41)
Foreign currency and commodity contracts 	Cost of goods sold 	(6)
Foreign currency and interest rate contracts 	Interest expense 	2
Foreign currency contracts 	Other income (loss) — net 	(24)
Income before income taxes 	(69)
Income taxes 	17
Consolidated net income 	$ 	(52)
Available-for-sale debt securities:
Sale of debt securities 	Other income (loss) — net 	$ 	1
Income before income taxes 	1
Income taxes 	—
Consolidated net income 	$ 	1
Pension and other postretirement benefit liabilities:
Divestitures 	Other income (loss) — net 	$ 	(2)
Curtailment loss (gain) 	Other income (loss) — net 	11
Amortization of net actuarial loss (gain) 	Other income (loss) — net 	25
Amortization of prior service cost (credit) 	Other income (loss) — net 	(1)
Income before income taxes 	33
Income taxes 	(7)
Consolidated net income 	$ 	26
Related to the sale of a portion of our ownership interest in CCEP. Refer to Note 2.
1
1
1
20

-- 23 of 69 --

NOTE 11: CHANGES IN EQUITY
The following tables provide a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and
equity attributable to noncontrolling interests (in millions):
Shareowners of The Coca-Cola Company
Three Months Ended March 28, 2025
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock
Non-controlling
Interests
December 31, 2024 	4,302 $ 	26,372 $ 	76,054 $ 	(16,843) $ 	1,760 $ 	19,801 $ 	(55,916) $ 	1,516
Comprehensive income (loss) 	— 	3,729 	3,330 	361 	— 	— 	— 	38
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.51 per share) 	— 	(2,195) 	(2,195) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(2) 	— 	— 	— 	— 	— 	(2)
Purchases of treasury stock 	(4) 	(279) 	— 	— 	— 	— 	(279) 	—
Impact related to stock-based
compensation plans 	6 	129 	— 	— 	— 	72 	57 	—
March 28, 2025 	4,304 $ 	27,754 $ 	77,189 $ 	(16,482) $ 	1,760 $ 	19,873 $ 	(56,138) $ 	1,552
Shareowners of The Coca-Cola Company
Three Months Ended March 29, 2024 Common Shares
Outstanding 	Total Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock Non-controlling
Interests
December 31, 2023 	4,308 $ 	27,480 $ 	73,782 $ 	(14,275) $ 	1,760 $ 	19,209 $ 	(54,535) $ 	1,539
Comprehensive income (loss) 	— 	2,932 	3,177 	(229) 	— 	— 	— 	(16)
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.485 per share) 	— 	(2,091) 	(2,091) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(2) 	— 	— 	— 	— 	— 	(2)
Divestitures 	— 	(4) 	— 	— 	— 	— 	— 	(4)
Purchases of treasury stock 	(10) 	(621) 	— 	— 	— 	— 	(621) 	—
Impact related to stock-based
compensation plans 	10 	252 	— 	— 	— 	112 	140 	—
March 29, 2024 	4,308 $ 	27,946 $ 	74,868 $ 	(14,504) $ 	1,760 $ 	19,321 $ 	(55,016) $ 	1,517
NOTE 12: SIGNIFICANT OPERATING AND NONOPERATING ITEMS
Other Operating Charges
During the three months ended March 28, 2025, the Company recorded other operating charges of $73 million. These charges consisted of $47 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, which brought the total liability to
$6,173 million and was paid in March 2025. Additionally, other operating charges included $11 million related to the Company’s productivity and reinvestment program,
$9 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $3 million for the amortization of noncompete
agreements related to the BA Sports Nutrition, LLC (“BodyArmor”) acquisition in 2021 and $3 million related to tax litigation expense.
During the three months ended March 29, 2024, the Company recorded other operating charges of $1,573 million. These charges consisted of $765 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition, $760 million related to the impairment of our BodyArmor
trademark and $36 million related to the Company’s productivity and reinvestment program. In addition, other operating charges included $7 million for transaction costs
related to the refranchising of our bottling operations in certain territories in India, $4 million for the amortization of noncompete agreements related to the BodyArmor
acquisition and $1 million related to tax litigation expense.
21

-- 24 of 69 --

Refer to Note 2 for additional information on the refranchising of our bottling operations in certain territories in India. Refer to Note 9 for additional information on the tax
litigation. Refer to Note 13 for additional information on the Company’s restructuring initiatives. Refer to Note 16 for additional information on the fairlife acquisition and the
BodyArmor impairment. Refer to Note 17 for the impact these charges had on our operating segments and Corporate.
Other Nonoperating Items
Equity Income (Loss) — Net
During the three months ended March 28, 2025 and March 29, 2024, the Company recorded net charges of $8 million and $25 million, respectively. These amounts represent
the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
Other Income (Loss) — Net
During the three months ended March 28, 2025, the Company recognized a net gain of $331 million related to the sale of a portion of our ownership interest in CCEP, an
impairment charge of $25 million related to an equity method investee in Latin America and a net loss of $19 million related to realized and unrealized gains and losses on
equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also recorded charges of $25 million and
$11 million for special termination benefits and a curtailment loss, respectively, related to non-U.S. pension activity.
During the three months ended March 29, 2024, the Company recognized net gains of $599 million and $293 million related to the refranchising of our bottling operations in
the Philippines and certain territories in India, respectively. The Company also recognized a net gain of $516 million related to the sale of our ownership interest in an equity
method investee in Thailand. Additionally, the Company recognized a net gain of $178 million related to realized and unrealized gains and losses on equity securities and
trading debt securities as well as realized gains and losses on available-for-sale debt securities.
Refer to Note 2 for additional information on the sale of our ownership interest in CCEP, the sale of our ownership interest in an equity method investee in Thailand and the
refranchising of our bottling operations. Refer to Note 4 for additional information on equity and debt securities. Refer to Note 14 for additional information on the non-U.S.
pension curtailment and special termination benefits. Refer to Note 16 for additional information on the impairment charge.
NOTE 13: RESTRUCTURING
Productivity and Reinvestment Program
In February 2012, the Company announced a productivity and reinvestment program designed to strengthen our brands and reinvest our resources to drive long-term profitable
growth. The program was expanded multiple times, with the last expansion occurring in April 2017. While most of the initiatives included in this program were substantially
completed by the end of 2024, certain initiatives, which are primarily designed to further simplify and standardize our organization, have been delayed and will be completed
during 2025.
During the three months ended March 28, 2025 and March 29, 2024, the Company incurred expenses of $11 million and $36 million, respectively, related to our productivity
and reinvestment program. These expenses primarily included internal and external costs associated with the implementation of the program’s initiatives and were recorded in
the line item other operating charges in our consolidated statements of income. Refer to Note 17 for the impact these expenses had on our operating segments and Corporate.
The Company has incurred total pretax expenses of $4,437 million related to this program since it commenced.
22

-- 25 of 69 --

NOTE 14: PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Net periodic benefit cost or income for our pension and other postretirement benefit plans consisted of the following (in millions):
Pension Plans
Other Postretirement
Benefit Plans
Three Months Ended
March 28,
2025 March 29,
2024 March 28,
2025 March 29,
2024
Service cost 	$ 	26 $ 	27 	$ 	1 $ 	1
Interest cost 	75 	77 	3 	4
Expected return on plan assets 	(104) 	(118) 	(1) 	(2)
Amortization of prior service cost (credit) 	— 	— 	(1) 	(1)
Amortization of net actuarial loss (gain) 	25 	26 	— 	(1)
Curtailment loss (gain) 	11 	— 	— 	—
Special termination benefits 	25 	— 	— 	—
Net periodic benefit cost (income) 	$ 	58 $ 	12 	$ 	2 $ 	1
The weighted-average expected long-term rates of return on plan assets used in computing 2025 net periodic benefit cost (income) were 7.00% for pension plans and 6.75% for other
postretirement benefit plans.
The curtailment loss and special termination benefits were related to the group annuity purchase (“buy-in”) for a non-U.S. defined benefit plan. The Company intends to convert the buy-in to a
buy-out in the future, at which time the insurer would assume full responsibility for the plan obligations.
All of the amounts in the table above, other than service cost, were recorded in the line item other income (loss) — net in our consolidated statements of income. During the
three months ended March 28, 2025, the Company contributed $11 million to our pension trusts, offset by a $61 million transfer of surplus non-U.S. plan assets from pension
trusts to general assets of the Company. We anticipate making additional contributions of approximately $18 million during the remainder of 2025. The Company contributed
$6 million to our pension trusts, offset by a $44 million transfer of surplus non-U.S. plan assets from pension trusts to general assets of the Company during the three months
ended March 29, 2024.
NOTE 15: INCOME TAXES
The Company recorded income taxes of $722 million (17.8% effective tax rate) and $687 million (17.7% effective tax rate) during the three months ended March 28, 2025 and
March 29, 2024, respectively.
The Company’s effective tax rates for the three months ended March 28, 2025 and March 29, 2024 vary from the statutory U.S. federal tax rate of 21.0%, primarily due to the
tax impact of significant operating and nonoperating items, as described in Note 12, along with the tax benefits of having significant earnings generated outside of the United
States and significant earnings generated in investments accounted for under the equity method, both of which are generally taxed at rates lower than the statutory U.S. federal
tax rate.
The Company’s effective tax rate for the three months ended March 28, 2025 included $143 million of net tax benefits related to various discrete tax items, including net
interest income of $53 million related to the IRS Tax Litigation Deposit recorded in the line item income taxes in our consolidated statement of income, in accordance with our
accounting policy, and a tax benefit of $85 million related to a change in the Company’s indefinite reinvestment assertion for certain foreign entities.
During the three months ended March 28, 2025, the Company invested $30 million in limited partnerships that receive tax credits and other tax benefits by constructing,
owning and operating alternative energy generation facilities. During the three months ended March 28, 2025, the Company received tax credits and other income tax benefits
of $9 million and recognized amortization expense of $7 million related to all of our investments of this nature. The amount of non-income tax-related activity and other returns
related to these investments was not material during the three months ended March 28, 2025. As of March 28, 2025, the carrying value of these investments was $65 million.
The Company recorded $123 million of unfunded commitments related to these investments in the line item accounts payable and accrued expenses in our consolidated balance
sheet as of March 28, 2025 and December 31, 2024. The Company expects to fulfill these unfunded commitments in 2025.
On November 18, 2020, the Tax Court issued the Opinion regarding the Company’s 2015 litigation with the IRS involving transfer pricing tax adjustments in which it
predominantly sided with the IRS. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that the blocked-income
regulations apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v. Commissioner (February 9, 2023) controlled as to the validity of those
regulations. On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of
1
2
2
1
2
23

-- 26 of 69 --

$2.7 billion for the 2007 through 2009 tax years. With applicable interest, the total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is
$6.0 billion. On October 22, 2024, the Company appealed the Tax Court’s decision to the U.S. Court of Appeals for the Eleventh Circuit. The Company filed its principal
appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March 12, 2025. The Company strongly disagrees with the Opinions and intends to vigorously defend
its positions. Refer to Note 9.
NOTE 16: FAIR VALUE MEASUREMENTS
Recurring Fair Value Measurements
The following tables summarize assets and liabilities measured at fair value on a recurring basis (in millions):
March 28, 2025 	Level 1 	Level 2 	Level 3 	Other
Netting
Adjustment
Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	1,778 $ 	166 $ 	17 	$ 	95 $ 	— 	$ 	2,056
Debt securities 	— 	1,763 	— 	— 	— 	1,763
Derivatives 	2 	260 	— 	— 	(234) 	28
Total assets 	$ 	1,780 $ 	2,189 $ 	17 	$ 	95 $ 	(234) 	$ 	3,847
Liabilities:
Derivatives 	$ 	2 $ 	1,086 $ 	— 	$ 	— $ 	(1,051) 	$ 	37
Total liabilities 	$ 	2 $ 	1,086 $ 	— 	$ 	— $ 	(1,051) 	$ 	37
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included
to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
The Company is obligated to return $18 million in cash collateral it has netted against its derivative position.
The Company has the right to reclaim $832 million in cash collateral it has netted against its derivative position.
The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $28 million in the line item other noncurrent assets and $37 million in
the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
3 	4
1
1
2 	5 	7
2 	6 	7
1
2
3
4
5
6
7
24

-- 27 of 69 --

December 31, 2024 	Level 1 	Level 2 	Level 3 	Other
Netting
Adjustment
Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	1,790 $ 	137 $ 	13 	$ 	94 $ 	— 	$ 	2,034
Debt securities 	— 	1,676 	— 	— 	— 	1,676
Derivatives 	2 	587 	— 	— 	(370) 	219
Total assets 	$ 	1,792 $ 	2,400 $ 	13 	$ 	94 $ 	(370) 	$ 	3,929
Liabilities:
Contingent consideration liability 	$ 	— $ 	— $ 	6,126 	$ 	— $ 	— 	$ 	6,126
Derivatives 	— 	1,119 	— 	— 	(1,097) 	22
Total liabilities 	$ 	— $ 	1,119 $ 	6,126 	$ 	— $ 	(1,097) 	$ 	6,148
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included
to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
Represents the fair value of the remaining milestone payment related to our acquisition of fairlife, which is contingent on fairlife achieving certain financial targets through 2024 and is payable in
2025. This milestone payment is based on agreed-upon formulas related to fairlife’s operating results, the resulting value of which is not subject to a ceiling. The fair value was determined using
discounted cash flow analyses. We are required to remeasure this liability to fair value quarterly, with any changes in the fair value recorded in income until the final milestone payment is made.
The Company was obligated to return $12 million in cash collateral it had netted against its derivative position.
The Company had the right to reclaim $735 million in cash collateral it had netted against its derivative position.
The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $102 million in the line item prepaid expenses and other current assets,
$117 million in the line item other noncurrent assets, and $22 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the composition of our
derivatives portfolio.
Gross realized and unrealized gains and losses on Level 3 assets and liabilities, excluding the contingent consideration liability, were not significant for the three months ended
March 28, 2025 and March 29, 2024.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not
significant for the three months ended March 28, 2025 and March 29, 2024.
Nonrecurring Fair Value Measurements
During the three months ended March 28, 2025, the Company recorded an other-than-temporary impairment charge of $25 million related to a joint venture in Latin America.
This impairment charge was derived using Level 3 inputs and was due to the joint venture’s restructuring and planned liquidation. This charge was recorded in the line item
other income (loss) — net in our consolidated statement of income.
During the three months ended March 29, 2024, the Company recorded an asset impairment charge of $760 million related to our BodyArmor trademark in North America,
which was primarily driven by revised projections of future operating results and higher discount rates resulting from changes in macroeconomic conditions since the
acquisition date. The fair value of this trademark was derived using discounted cash flow analyses based on Level 3 inputs. This charge was recorded in the line item other
operating charges in our consolidated statement of income. The remaining carrying value of the trademark is $3,400 million.
Other Fair Value Disclosures
The carrying values of cash and cash equivalents, short-term investments, trade accounts receivable, accounts payable and accrued expenses, and loans and notes payable
approximate their fair values because of the relatively short-term maturities of these financial instruments. The fair value of our long-term debt is estimated using Level 2 inputs
based on quoted prices for those instruments. Where quoted prices are not available, the fair value is estimated using discounted cash flows and market-based expectations for
interest rates, credit risk and the contractual terms of the debt instruments. As of March 28, 2025, the carrying value and fair value of our long-term debt, including the current
portion, were $43,693 million and $38,736 million, respectively. As of December 31, 2024, the carrying value and fair value of our long-term debt, including the current
portion, were $43,023 million and $38,052 million, respectively.
3 	4
1
1
2 	6 	8
5
2 	7 	8
1
2
3
4
5
6
7
8
25

-- 28 of 69 --

NOTE 17: OPERATING SEGMENTS
The Global Ventures operating segment was established primarily to oversee the Company’s ownership of Costa Limited (“Costa”), innocent and doğadan, as well as the fees
earned pursuant to distribution coordination agreements between the Company and Monster Beverage Corporation (“Monster”). In November 2024, we announced plans to
sunset our Global Ventures operating segment to streamline and simplify our operating structure. Effective January 1, 2025, the results of our Costa (excluding the ready-to-
drink business), innocent and doğadan businesses are reported within the Company’s Europe, Middle East and Africa operating segment. Costa’s ready-to-drink business and
the fees related to Monster are reported in the respective geographic operating segments. Our historical operating segment reporting disclosed below has been recast to reflect
our current organizational structure.
Information about our Company’s operations by operating segment and Corporate is as follows (in millions):
Europe, Middle
East & Africa Latin
America North
America 	Asia Pacific Bottling
Investments 	Corporate 	Eliminations 	Consolidated
Three Months Ended March 28, 2025
Net operating revenues:
Third party 	$ 	2,481 $ 	1,477 $ 	4,359 $ 	1,325 $ 	1,461 $ 	26 $ 	— $ 	11,129
Intersegment 	176 	— 	2 	96 	2 	— 	(276) 	—
Total net operating revenues 	2,657 	1,477 	4,361 	1,421 	1,463 	26 	(276) 	11,129
Cost of goods sold 	759 	274 	2,106 	390 	1,010 	(100) 	(276) 	4,163
Selling, general and administrative expenses 	833 	299 	914 	407 	334 	447 	— 	3,234
Other operating charges 	— 	— 	— 	— 	— 	73 	— 	73
Operating income (loss) 	$ 	1,065 $ 	904 $ 	1,341 $ 	624 $ 	119 $ 	(394) $ 	— $ 	3,659
Interest income 	180
Interest expense 	387
Equity income (loss) — net 	351
Other income (loss) — net 	254
Income before income taxes 	$ 	4,057
Other segment information:
Capital expenditures 	$ 	41 $ 	— $ 	115 $ 	1 $ 	105 $ 	47 $ 	— $ 	309
Depreciation and amortization 	44 	7 	81 	12 	76 	47 	— 	267
Three Months Ended March 29, 2024
Net operating revenues:
Third party 	$ 	2,435 $ 	1,530 $ 	4,224 $ 	1,265 $ 	1,815 $ 	31 $ 	— $ 	11,300
Intersegment 	197 	— 	2 	216 	2 	— 	(417) 	—
Total net operating revenues 	2,632 	1,530 	4,226 	1,481 	1,817 	31 	(417) 	11,300
Cost of goods sold 	733 	249 	2,110 	399 	1,265 	(104) 	(417) 	4,235
Selling, general and administrative expenses 	819 	336 	859 	425 	396 	516 	— 	3,351
Other operating charges 	— 	— 	760 	— 	— 	813 	— 	1,573
Operating income (loss) 	$ 	1,080 $ 	945 $ 	497 $ 	657 $ 	156 $ 	(1,194) $ 	— $ 	2,141
Interest income 	246
Interest expense 	382
Equity income (loss) — net 	354
Other income (loss) — net 	1,513
Income before income taxes 	$ 	3,872
Other segment information:
Capital expenditures 	$ 	38 $ 	— $ 	101 $ 	4 $ 	177 $ 	50 $ 	— $ 	370
Depreciation and amortization 	45 	7 	77 	11 	91 	31 	— 	262
26

-- 29 of 69 --

Information about total assets by segment is not disclosed because such information is not regularly provided to, or used by, our Chief Operating Decision Maker.
During the three months ended March 28, 2025 and March 29, 2024, our operating segments and Corporate were impacted by acquisition and divestiture activities. Refer to
Note 2. Additionally, during the three months ended March 28, 2025, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) was reduced by $47 million for Corporate due to the remeasurement of our contingent consideration liability to fair value in conjunction with the
fairlife acquisition.
• Operating income (loss) was reduced by $11 million for Corporate due to the Company’s productivity and reinvestment program. Refer to Note 13.
• Operating income (loss) was reduced by $9 million for Corporate due to a payment under an indemnification agreement entered into as a part of the refranchising of
certain of our bottling operations.
• Operating income (loss) was reduced by $3 million for Corporate due to charges related to our acquisition of BodyArmor. Refer to Note 12.
During the three months ended March 29, 2024, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) was reduced by $765 million for Corporate due to the remeasurement of our contingent consideration liability to fair value in conjunction with
the fairlife acquisition. Refer to Note 16.
• Operating income (loss) was reduced by $760 million for North America due to the impairment of our BodyArmor trademark. Refer to Note 16.
• Operating income (loss) was reduced by $36 million for Corporate due to the Company’s productivity and reinvestment program. Refer to Note 13.
• Operating income (loss) was reduced by $7 million for Corporate due to transaction costs related to the refranchising of our bottling operations in certain territories in
India. Refer to Note 2.
• Operating income (loss) was reduced by $4 million for Corporate due to charges related to our acquisition of BodyArmor. Refer to Note 12.
27

-- 30 of 69 --

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
When used in this report, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Recoverability of Equity Method Investments and Indefinite-Lived Intangible Assets
Our Company faces many uncertainties and risks related to various economic, political and regulatory environments in the countries and territories in which we operate,
particularly in developing and emerging markets. Refer to the headings “Item 1A. Risk Factors” in Part I and “Our Business — Challenges and Risks” in Part II of our Annual
Report on Form 10-K for the year ended December 31, 2024, as well as the heading “Operations Review” below for additional information related to our present business
environment. As a result, management must make numerous assumptions, which involve a significant amount of judgment, when performing impairment tests of equity method
investments and indefinite-lived intangible assets in various regions around the world. The performance of impairment tests involves critical accounting estimates. These
estimates require significant management judgment and include inherent uncertainties. Factors that management must estimate include, among others, the economic lives of the
assets, sales volume, pricing, royalty rates, cost of raw materials, delivery costs, long-term growth rates, discount rates, marketing spending, foreign currency exchange rates,
tax rates, capital spending and proceeds from the sale of assets. The variability of these factors depends on a number of conditions, and thus our accounting estimates may
change from period to period. These factors are even more difficult to estimate given the highly volatile global financial markets. As these factors are often interdependent and
may not change in isolation, we do not believe it is practicable or meaningful to present the impact of changing a single factor.
In November 2021, the Company acquired the remaining 85% ownership interest in, and now owns 100% of, BodyArmor, which offers a line of sports performance and
hydration beverages. During 2021, in conjunction with acquiring the remaining ownership interest, we recognized a noncash gain of $834 million resulting from the
remeasurement of our previously held equity interest in BodyArmor to fair value. The Company allocated $4.2 billion of the $5.6 billion purchase price to the BodyArmor
trademark. During the three months ended March 29, 2024, the operating results related to the trademark were lower than expected. Therefore, the Company revised its
projections of the future operating results related to the trademark, which triggered the need to update its impairment analysis. As a result, the Company concluded that the fair
value of the trademark was less than its carrying value and recorded an impairment charge of $760 million. The decrease in fair value was primarily driven by the revised
projections of future operating results as well as higher discount rates resulting from changes in macroeconomic conditions since the acquisition date. As of March 28, 2025, the
fair value of this trademark approximates its carrying value. If the near-term operating results of this trademark do not achieve our revised financial projections, or if the
macroeconomic conditions change causing the discount rate to increase without an offsetting increase in the operating results, it is likely that we would be required to recognize
an additional impairment charge. Management will continue to monitor the fair value of this trademark in future periods.
OPERATIONS REVIEW
Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of
sales in the beverage business may be affected by weather conditions.
While our operations are primarily local, we remain subject to global trade dynamics, which may impact certain components of our cost structure as well as the cost structures
of our bottlers and our customers and may affect consumer sentiment across our markets.
The Global Ventures operating segment was established primarily to oversee the Company’s ownership of Costa, innocent and doğadan, as well as the fees earned pursuant to
distribution coordination agreements between the Company and Monster. In November 2024, we announced plans to sunset our Global Ventures operating segment to
streamline and simplify our operating structure. Effective January 1, 2025, the results of our Costa (excluding the ready-to-drink business), innocent and doğadan businesses are
reported within the Company’s Europe, Middle East and Africa operating segment. Costa’s ready-to-drink business and the fees related to Monster are reported in the respective
geographic operating segments. Our historical operating segment information disclosed below has been recast to reflect our current organizational structure.
28

-- 31 of 69 --

Structural Changes, Acquired Brands and Newly Licensed Brands
In order to continually improve upon the Company’s operating performance, from time to time we engage in buying and selling ownership interests in bottling partners and
other manufacturing operations. In addition, we periodically acquire brands and their related operations or enter into license agreements for certain brands to supplement our
beverage offerings. These items impact our operating results and certain key metrics used by management in assessing the Company’s performance.
Unit case volume growth is a key metric used by management to evaluate the Company’s performance because it measures demand for our products at the consumer level. The
Company’s unit case volume represents the number of unit cases (or unit case equivalents) of Company beverage products directly or indirectly sold by the Company and its
bottling partners to customers or consumers and, therefore, reflects unit case volume for both consolidated and unconsolidated bottlers. Refer to the heading “Beverage
Volume” below.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or
used in finished products sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-drink beverage products, concentrate sales volume represents
the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers.
Refer to the heading “Beverage Volume” below.
When we analyze our net operating revenues, we generally consider the following factors: (1) volume growth (concentrate sales volume or unit case volume, as applicable); (2)
changes in price, product and geographic mix; (3) foreign currency exchange rate fluctuations; and (4) acquisitions and divestitures (including structural changes as defined
below), as applicable. Refer to the heading “Net Operating Revenues” below. The Company sells concentrates and syrups to both consolidated and unconsolidated bottling
partners. The ownership structure of our bottling partners impacts the timing of recognizing concentrate revenue and concentrate sales volume. When we sell concentrates or
syrups to our consolidated bottling partners, we do not recognize the concentrate revenue or concentrate sales volume until the bottling partner has sold finished products
manufactured from the concentrates or syrups to a third party. When we sell concentrates or syrups to our unconsolidated bottling partners, we recognize the concentrate
revenue and concentrate sales volume when the concentrates or syrups are sold to the bottling partner. The subsequent sale of the finished products manufactured from the
concentrates or syrups to a third party does not impact the timing of recognizing the concentrate revenue or concentrate sales volume. When we account for an unconsolidated
bottling partner as an equity method investment, we eliminate the intercompany profit related to concentrate sales to the extent of our ownership interest, until the equity
method investee has sold finished products manufactured from the concentrates or syrups to a third party. We typically report unit case volume when finished products
manufactured from the concentrates or syrups are sold to a third party, regardless of our ownership interest in the bottling partner, if any.
We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a component of acquisitions and divestitures. Typically, structural
changes do not impact the Company’s unit case volume on a consolidated basis or at the geographic operating segment level. We recognize unit case volume for all sales of
Company beverage products, regardless of our ownership interest in the bottling partner, if any. However, the unit case volume reported by our Bottling Investments operating
segment is generally impacted by structural changes because it only includes the unit case volume of our consolidated bottling operations. Refer to Note 2 of Notes to
Consolidated Financial Statements for additional information on the Company’s acquisitions and divestitures.
“Acquired brands” refers to brands acquired during the past 12 months. Typically, the Company has not reported unit case volume or recognized concentrate sales volume
related to acquired brands in periods prior to the closing of a transaction. Therefore, the unit case volume and concentrate sales volume related to an acquired brand are
incremental to prior year volume. We generally do not consider the acquisition of a brand to be a structural change.
“Licensed brands” refers to brands not owned by the Company but for which we hold certain rights, generally including, but not limited to, distribution rights, and from which
we derive an economic benefit when the related products are sold. Typically, the Company has not reported unit case volume or recognized concentrate sales volume related to
a licensed brand in periods prior to the beginning of the term of a license agreement. Therefore, in the year that a license agreement is entered into, the unit case volume and
concentrate sales volume related to a licensed brand are incremental to prior year volume. We generally do not consider the licensing of a brand to be a structural change.
In January, February and December 2024, the Company refranchised our bottling operations in certain territories in India, and in February 2024, the Company refranchised our
bottling operations in Bangladesh and the Philippines. The impact of each of these refranchisings has been included as a structural change in our analysis of net operating
revenues on a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments for the three months ended March 28, 2025.
29

-- 32 of 69 --

Beverage Volume
We measure the volume of Company beverage products sold in two ways: (1) unit cases of finished products and (2) concentrate sales. As used in this report, “unit case” means
a unit of measurement equal to 192 U.S. fluid ounces of finished beverage (24 eight-ounce servings), with the exception of unit case equivalents for Costa non-ready-to-drink
beverage products, which are primarily measured in number of transactions; and “unit case volume” means the number of unit cases (or unit case equivalents) of Company
beverage products directly or indirectly sold by the Company and its bottling partners to customers or consumers. Unit case volume primarily consists of beverage products
bearing Company trademarks. Also included in unit case volume are certain brands licensed to, or distributed by, our Company, and brands owned by Coca-Cola system bottlers
for which our Company provides marketing support and from the sale of which we derive an economic benefit. In addition, unit case volume includes sales by certain joint
ventures in which the Company has an ownership interest. We believe unit case volume is one of the indicators of the underlying strength of the Coca-Cola system because it
measures demand for our products at the consumer level. The unit case volume numbers used in this report are derived based on estimates received by the Company from its
bottling partners and distributors. Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in
unit case equivalents) sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-drink beverage products,
concentrate sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the
Company to customers or consumers. Unit case volume and concentrate sales volume growth rates are not necessarily equal during any given period. Factors such as
seasonality, bottlers’ inventory practices, supply point changes, timing of price increases, new product introductions and changes in product mix can create differences between
unit case volume and concentrate sales volume growth rates. In addition to these items, the impact of unit case volume from certain joint ventures in which the Company has an
ownership interest, but to which the Company does not sell concentrates, syrups, source waters or powders/minerals, may give rise to differences between unit case volume and
concentrate sales volume growth rates.
Information about our volume growth worldwide and for each of our operating segments is as follows:
Percent Change 2025 versus 2024
Three Months Ended
March 28, 2025
Unit Cases 	Concentrate Sales
Worldwide 	2 % 	1 %
Europe, Middle East & Africa 	3 	1
Latin America 	— 	(3)
North America 	(3) 	(4)
Asia Pacific 	6 	2
Bottling Investments 	(17) 	N/A
Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only.
Geographic operating segment data reflects unit case volume growth for all bottlers, both consolidated and unconsolidated, and distributors in the applicable geographic areas. Unit case volume
growth for Costa retail stores is reflected in the Europe, Middle East and Africa operating segment data.
Unit case volume percent change is based on average daily sales. Unit case volume growth based on average daily sales is computed by comparing the average daily sales in each of the
corresponding periods. Average daily sales are the unit cases sold during the period divided by the number of days in the period.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished
beverages sold by, the Company to its bottling partners or other customers and is not based on average daily sales. For Costa non-ready-to-drink beverage products, concentrate sales volume
represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers and is not
based on average daily sales. Each of our quarters, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. As a result, the first
quarter of 2025 had two fewer days when compared to the first quarter of 2024, and the fourth quarter of 2025 will have one additional day when compared to the fourth quarter of 2024.
After considering the impact of structural changes, unit case volume for Bottling Investments for the three months ended March 28, 2025 grew 1%.
After considering the impact of structural changes, concentrate sales volume for Asia Pacific for the three months ended March 28, 2025 grew 8%.
1,2,3 	4
6
5
1
2
3
4
5
6
30

-- 33 of 69 --

Unit Case Volume
Although a significant portion of our Company’s net operating revenues is not based directly on unit case volume, we believe unit case volume performance is one of the
indicators of the underlying strength of the Coca-Cola system because it measures demand for our products at the consumer level.
Unit case volume in Europe, Middle East and Africa increased 3%, which included 3% growth in both Trademark Coca-Cola and sparkling flavors, 2% growth in water, sports,
coffee and tea, as well as growth in energy drinks, partially offset by a 5% decline in juice, value-added dairy and plant-based beverages. The operating segment’s volume
performance included an increase in unit case volume of 11% in the Eurasia and Middle East operating unit, 1% in the Africa operating unit and growth in energy drinks,
partially offset by a decline of 1% in the Europe operating unit.
Unit case volume in Latin America was even, which included 1% growth in both Trademark Coca-Cola and water, sports, coffee and tea, as well as growth in energy drinks,
offset by a 4% decline in sparkling flavors. Unit case volume in juice, value-added dairy and plant-based beverages was even. The operating segment’s volume performance
included 4% growth in Brazil and 17% growth in Argentina, offset by a decline of 3% in Mexico.
Unit case volume in North America decreased 3%, which included a 3% decline in Trademark Coca-Cola, a 6% decline in water, sports, coffee and tea, and a 1% decline in
sparkling flavors, partially offset by growth in energy drinks. Unit case volume in juice, value-added dairy and plant-based beverages was even.
Unit case volume in Asia Pacific increased 6%, which included 6% growth in sparkling flavors, 7% growth in water, sports, coffee and tea, 3% growth in Trademark Coca-
Cola, 4% growth in juice, value-added dairy and plant-based beverages and growth in energy drinks. The operating segment’s volume performance included 16% growth in the
India and Southwest Asia operating unit, 6% growth in the Greater China and Mongolia operating unit, 1% growth in the Japan and South Korea operating unit and growth in
energy drinks, partially offset by a decline of 2% in the ASEAN and South Pacific operating unit.
Unit case volume for Bottling Investments decreased 17%, driven by the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in
India.
Concentrate Sales Volume
During the three months ended March 28, 2025, worldwide concentrate sales volume increased 1% and unit case volume increased 2% compared to the three months ended
March 29, 2024. Concentrate sales volume growth is calculated based on the amount sold during the reporting periods, which is impacted by the number of days. Conversely,
unit case volume growth is calculated based on average daily sales, which is not impacted by the number of days in the reporting periods. The first quarter of 2025 had two
fewer days when compared to the first quarter of 2024, which contributed to the differences between concentrate sales volume and unit case volume growth rates on a
consolidated basis and for the individual operating segments. Additionally, the differences between concentrate sales volume and unit case volume growth rates for the
operating segments were impacted by the timing of concentrate shipments. We expect the differences between concentrate sales volume and unit case volume growth rates to
lessen over the remainder of the year.
31

-- 34 of 69 --

Net Operating Revenues
During the three months ended March 28, 2025, net operating revenues were $11,129 million, compared to $11,300 million during the three months ended March 29, 2024, a
decrease of $171 million, or 2%.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis
and for each of our operating segments:
Percent Change 2025 versus 2024
Volume Price, Product &
Geographic Mix Foreign Currency
Fluctuations Acquisitions &
Divestitures 	Total
Consolidated 	1 % 	5 % 	(5)% 	(3)% 	(2)%
Europe, Middle East & Africa 	1 	6 	(6) 	— 	1
Latin America 	(3) 	16 	(16) 	— 	(3)
North America 	(4) 	8 	— 	— 	3
Asia Pacific 	8 	(1) 	(6) 	(5) 	(4)
Bottling Investments 	(1) 	3 	(3) 	(18) 	(20)
Note: Certain rows may not add due to rounding.
Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments after considering the impact of
acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues attributable to the increase (decrease) in unit
case volume computed by comparing the total sales (rather than the average daily sales) in each of the corresponding periods after considering the impact of structural changes, if any. Our
Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer to the heading
“Beverage Volume” above.
Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.
“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our
bottling partners; the mix of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that
providing investors with price, product and geographic mix enhances their understanding about the combined impact that these items had on the Company’s net operating
revenues. The impact of price, product and geographic mix is calculated by subtracting the change in net operating revenues resulting from volume increases or decreases,
fluctuations in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating revenues. Management uses this measure in making
financial, operating and planning decisions and in evaluating the Company’s performance.
Price, product and geographic mix had a 5% favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of
factors and events including, but not limited to, the following:
• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing, partially offset by unfavorable mix;
• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, and favorable mix;
• North America — favorable pricing initiatives and favorable mix;
• Asia Pacific — unfavorable mix, partially offset by favorable pricing initiatives; and
• Bottling Investments — favorable pricing initiatives, partially offset by unfavorable mix.
Fluctuations in foreign currency exchange rates unfavorably impacted our consolidated net operating revenues by 5%. This unfavorable impact was primarily due to a stronger
U.S. dollar compared to certain foreign currencies, including the Mexican peso, Brazilian real, Argentine peso, Ethiopian birr, euro, Zimbabwe gold, and Nigerian naira, which
had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Bottling Investments operating segments. Refer to the heading “Liquidity, Capital
Resources and Financial Position — Foreign Exchange” below.
1 	2
1
2
32

-- 35 of 69 --

“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The
impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we
removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that
quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their
understanding of the Company’s net operating revenue performance by improving their ability to compare our period-to-period results. Management considers the impact of
acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for
additional information related to acquisitions and divestitures.
Net operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency exchange rate fluctuations; and acquisitions and
divestitures. The size and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we
expect foreign currency exchange rate fluctuations will have an unfavorable impact on our full year 2025 net operating revenues.
Gross Profit Margin
Gross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information
related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses
this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
Our gross profit margin increased to 62.6% for the three months ended March 28, 2025, compared to 62.5% for the three months ended March 29, 2024. The increase was
primarily due to the impact of favorable pricing initiatives and the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India,
partially offset by the unfavorable impact of foreign currency exchange rate fluctuations and higher commodity costs.
Selling, General and Administrative Expenses
During the three months ended March 28, 2025, selling, general and administrative expenses was $3,234 million, compared to $3,351 million during the three months ended
March 29, 2024, a decrease of $117 million, or 4%. The decrease was primarily due to the refranchising of our bottling operations in the Philippines, Bangladesh and certain
territories in India as well as an unfavorable foreign currency exchange rate impact of 3%. Advertising expenses for the three months ended March 28, 2025 and March 29,
2024 were $1,089 million and $1,161 million, respectively.
As of March 28, 2025, we had $391 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we
expect to recognize over a weighted-average period of 2.0 years as stock-based compensation expense. This expected cost does not include the impact of any future stock-based
compensation awards.
Other Operating Charges
Other operating charges incurred by our operating segments and Corporate were as follows (in millions):
Three Months Ended
March 28,
2025 March 29,
2024
Europe, Middle East & Africa 	$ 	— $ 	—
Latin America 	— 	—
North America 	— 	760
Asia Pacific 	— 	—
Bottling Investments 	— 	—
Corporate 	73 	813
Total 	$ 	73 $ 	1,573
During the three months ended March 28, 2025, the Company recorded other operating charges of $73 million. These charges consisted of $47 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, which brought the total liability to $6,173 million
and was paid in March 2025. Additionally, other operating charges included $11 million related to the Company’s productivity and reinvestment program, $9 million related to
an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $3 million for the amortization of noncompete agreements related
to the BodyArmor acquisition and $3 million related to tax litigation expense.
33

-- 36 of 69 --

During the three months ended March 29, 2024, the Company recorded other operating charges of $1,573 million. These charges consisted of $765 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife, $760 million related to the impairment of our BodyArmor
trademark and $36 million related to the Company’s productivity and reinvestment program. In addition, other operating charges included $7 million for transaction costs
related to the refranchising of our bottling operations in certain territories in India, $4 million for the amortization of noncompete agreements related to the BodyArmor
acquisition and $1 million related to tax litigation expense.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling operations in certain territories in India. Refer to
Note 9 of Notes to Consolidated Financial Statements for additional information on the tax litigation. Refer to Note 13 of Notes to Consolidated Financial Statements for
additional information on the Company’s restructuring initiatives. Refer to Note 16 of Notes to Consolidated Financial Statements for additional information on the fairlife
acquisition and the BodyArmor impairment. Refer to Note 17 of Notes to Consolidated Financial Statements for the impact these charges had on our operating segments and
Corporate.
Operating Income and Operating Margin
Information about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:
Three Months Ended
March 28,
2025 March 29,
2024
Europe, Middle East & Africa 	29.1 % 	50.5 %
Latin America 	24.7 	44.1
North America 	36.7 	23.2
Asia Pacific 	17.1 	30.7
Bottling Investments 	3.2 	7.3
Corporate 	(10.8) 	(55.8)
Total 	100.0 % 	100.0 %
Operating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful
information related to the profitability of our business after considering all of the selling, general and administrative expenses and other operating charges
incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
Information about our operating margin on a consolidated basis and for each of our operating segments and Corporate is as follows:
Three Months Ended
March 28,
2025 March 29,
2024
Consolidated 	32.9 % 	18.9 %
Europe, Middle East & Africa 	42.9 	44.4
Latin America 	61.2 	61.7
North America 	30.8 	11.8
Asia Pacific 	47.1 	51.9
Bottling Investments 	8.1 	8.6
Corporate 	* 	*
* Calculation is not meaningful.
During the three months ended March 28, 2025, operating income was $3,659 million, compared to $2,141 million during the three months ended March 29, 2024, an increase
of $1,518 million, or 71%. The increase was driven by an increase in concentrate sales volume of 1%, favorable pricing initiatives and lower other operating charges, partially
offset by the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India; higher commodity costs; and an unfavorable foreign
currency exchange rate impact of 18%.
Fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 18% due to a stronger U.S. dollar compared to certain foreign
currencies, including the Mexican peso, Brazilian real, Argentine peso, euro, and Zimbabwe gold, which had an unfavorable impact on our Latin America and Europe, Middle
East and Africa operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
34

-- 37 of 69 --

The Europe, Middle East and Africa operating segment reported operating income of $1,065 million and $1,080 million for the three months ended March 28, 2025 and
March 29, 2024, respectively. The decrease in operating income was primarily driven by higher commodity costs, increased marketing spending, higher operating expenses and
an unfavorable foreign currency exchange rate impact of 9%, partially offset by an increase in concentrate sales volume of 1% and favorable pricing initiatives.
Latin America reported operating income of $904 million and $945 million for the three months ended March 28, 2025 and March 29, 2024, respectively. The decrease in
operating income was primarily driven by a decrease in concentrate sales volume of 3%, higher commodity costs and an unfavorable foreign currency exchange rate impact of
22%, partially offset by favorable pricing initiatives and lower operating expenses.
Operating income for North America for the three months ended March 28, 2025 and March 29, 2024 was $1,341 million and $497 million, respectively. The increase in
operating income was primarily driven by favorable pricing initiatives and lower other operating charges due to the impairment of our BodyArmor trademark in the prior year,
partially offset by a decrease in concentrate sales volume of 4%, higher commodity costs, increased marketing spending, higher operating expenses and an unfavorable foreign
currency exchange rate impact of 1%. Refer to Note 16 of Notes to Consolidated Financial Statements for additional information on the impairment of our BodyArmor
trademark.
Asia Pacific’s operating income for the three months ended March 28, 2025 and March 29, 2024 was $624 million and $657 million, respectively. The decrease in operating
income was primarily driven by the impact of structural changes, higher operating expenses and an unfavorable foreign currency exchange rate impact of 11%, partially offset
by concentrate sales volume growth of 8%, lower commodity costs and lower marketing spending due to timing.
Bottling Investments’ operating income for the three months ended March 28, 2025 and March 29, 2024 was $119 million and $156 million, respectively. The decrease in
operating income was primarily driven by the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India, higher commodity
costs, higher operating expenses and an unfavorable foreign currency exchange rate impact of 4%, partially offset by favorable pricing initiatives.
Corporate’s operating loss for the three months ended March 28, 2025 and March 29, 2024 was $394 million and $1,194 million, respectively. Operating loss in 2025 decreased
primarily as a result of lower operating expenses and lower other operating charges, primarily due to the remeasurement of our contingent consideration liability to fair value in
conjunction with the fairlife acquisition. Refer to Note 16 of Notes to Consolidated Financial Statements for additional information on the fairlife acquisition.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have an unfavorable impact on our full year 2025
operating income.
Interest Income
During the three months ended March 28, 2025, interest income was $180 million, compared to $246 million during the three months ended March 29, 2024, a decrease of
$66 million, or 27%. The decrease was primarily driven by lower average investment balances on our Corporate and certain international investments.
Interest Expense
During the three months ended March 28, 2025, interest expense was $387 million, compared to $382 million during the three months ended March 29, 2024, an increase of
$5 million, or 1%. The increase was primarily due to the impact of higher debt balances, partially offset by lower rates on derivative instruments compared to the prior year.
Equity Income (Loss) — Net
During the three months ended March 28, 2025, equity income was $351 million, compared to equity income of $354 million during the three months ended March 29, 2024, a
decrease of $3 million, or 1%.
Other Income (Loss) — Net
During the three months ended March 28, 2025, other income (loss) — net was income of $254 million. The Company recognized a net gain of $331 million related to the sale
of a portion of our ownership interest in CCEP, an impairment charge of $25 million related to an equity method investee in Latin America and a net loss of $19 million related
to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. Additionally,
the Company recognized net foreign currency exchange losses of $16 million, $24 million of costs related to our trade accounts receivable factoring program and dividend
income of $55 million. Other income (loss) — net also included expense of $33 million related to the non-service cost components of net periodic benefit cost, which included
35

-- 38 of 69 --

charges of $25 million and $11 million for special termination benefits and a curtailment loss, respectively, related to non-U.S. pension activity.
During the three months ended March 29, 2024, other income (loss) — net was income of $1,513 million. The Company recognized net gains of $599 million and $293 million
related to the refranchising of our bottling operations in the Philippines and certain territories in India, respectively. The Company also recognized a net gain of $516 million
related to the sale of our ownership interest in an equity method investee in Thailand. Additionally, the Company recognized a net gain of $178 million related to realized and
unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities, recognized net foreign
currency exchange losses of $68 million and recorded $22 million of costs related to our trade accounts receivable factoring program. Other income (loss) — net also included
income of $15 million related to the non-service cost components of net periodic benefit cost and dividend income of $25 million.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on the sale of our ownership interest in CCEP, the sale of our ownership interest in an
equity method investee in Thailand and the refranchising of our bottling operations. Refer to Note 4 of Notes to Consolidated Financial Statements for additional information
on equity and debt securities. Refer to Note 14 of Notes to Consolidated Financial Statements for additional information on net periodic benefit cost or income. Refer to Note
16 of Notes to Consolidated Financial Statements for additional information on the impairment charge.
Income Taxes
The Company recorded income taxes of $722 million (17.8% effective tax rate) and $687 million (17.7% effective tax rate) during the three months ended March 28, 2025 and
March 29, 2024, respectively.
The Company’s effective tax rates for the three months ended March 28, 2025 and March 29, 2024 vary from the statutory U.S. federal tax rate of 21.0%, primarily due to the
tax impact of significant operating and nonoperating items, as described in Note 12 of Notes to Consolidated Financial Statements, along with the tax benefits of having
significant earnings generated outside of the United States and significant earnings generated in investments accounted for under the equity method, both of which are generally
taxed at rates lower than the statutory U.S. federal tax rate.
The Company’s effective tax rate for the three months ended March 28, 2025 included $143 million of net tax benefits related to various discrete tax items, including net
interest income of $53 million related to the IRS Tax Litigation Deposit recorded in the line item income taxes in our consolidated statement of income, in accordance with our
accounting policy, and a tax benefit of $85 million related to a change in the Company’s indefinite reinvestment assertion for certain foreign entities.
On November 18, 2020, the Tax Court issued the Opinion regarding the Company’s 2015 litigation with the IRS involving transfer pricing tax adjustments in which it
predominantly sided with the IRS. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that the blocked-income
regulations apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v. Commissioner (February 9, 2023) controlled as to the validity of those
regulations. The Company strongly disagrees with the Opinions and intends to vigorously defend its positions. Refer to Note 9 of Notes to Consolidated Financial Statements
for additional information on the tax litigation.
At the end of each quarter, we make our best estimate of the effective tax rate expected to be applicable for the full fiscal year. This estimate reflects, among other items, our
best estimate of operating results and foreign currency exchange rates. Based on current tax laws, including the impact of several countries enacting global minimum tax
regulations, the Company’s effective tax rate in 2025 is expected to be approximately 20.8% before considering the potential impact of any significant operating and
nonoperating items that may affect our effective tax rate. This rate does not include the impact of the ongoing tax litigation with the IRS, if the Company were not to prevail.
Many jurisdictions have enacted legislation and adopted policies resulting from the Organization for Economic Co-operation and Development’s (“OECD”) Anti-Base Erosion
and Profit Shifting project. The OECD is currently coordinating a two-pillared project on behalf of the G20 and other participating countries which would grant additional
taxing rights over profits earned by multinational enterprises to the countries in which their products are sold and services rendered. Pillar One would allow countries to
reallocate a portion of profits earned by multinational businesses with an annual global revenue exceeding €20 billion and a profit margin of over 10% to applicable market
jurisdictions. While the OECD issued draft language for the international implementation of Pillar One in October 2023, both the substantive rules and implementation process
remain under discussion at the OECD, so the timetable for any implementation remains uncertain.
In December 2021, the OECD issued Pillar Two model rules which would establish a global per-country minimum tax of 15%, and the European Union has approved a
directive requiring member states to incorporate similar provisions into their respective domestic laws. The directive requires, with certain limited exceptions, the rules to
initially become effective for fiscal years starting on or after December 31, 2023. Numerous countries have enacted legislation that implemented certain aspects of Pillar Two
effective January 1, 2024, while many others have indicated their intent to adopt, or have adopted, legislation effective in
36

-- 39 of 69 --

2025. The OECD and implementing countries are expected to continue to make further revisions to their legislation and release additional guidance. The Company will
continue to monitor developments to determine any potential impact in the countries in which we operate.
LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION
We believe our ability to generate cash flows from operating activities is one of the fundamental strengths of our business. Refer to the heading “Cash Flows from Operating
Activities” below. The Company does not typically raise capital through the issuance of stock. Instead, we use debt financing to lower our overall cost of capital and increase
our return on shareowners’ equity. Refer to the heading “Cash Flows from Financing Activities” below. We have a history of borrowing funds both domestically and
internationally at reasonable interest rates, and we expect to be able to continue to borrow funds at reasonable rates over the long term. Our debt financing also includes the use
of a commercial paper program. We currently have the ability to borrow funds in this market at levels that are consistent with our debt financing strategy, and we expect to
continue to be able to do so in the future. The Company regularly reviews its optimal mix of short-term and long-term debt.
The Company’s cash, cash equivalents, short-term investments and marketable securities totaled $13.8 billion as of March 28, 2025. In addition to these funds, our commercial
paper program, and our ability to issue long-term debt, we had $4.6 billion in unused backup lines of credit for general corporate purposes as of March 28, 2025. These backup
lines of credit expire at various times through 2030.
Our current payment terms with the majority of our suppliers are 120 days. Certain financial institutions offer a voluntary supply chain finance program which enables our
suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions on a non-recourse basis at a rate that leverages our credit rating and
thus may be more beneficial to them. We do not believe there is a risk that our payment terms will be shortened in the near future. Refer to Note 7 of Notes to Consolidated
Financial Statements for additional information.
The Company has a trade accounts receivable factoring program in certain countries. Under this program, we can elect to sell trade accounts receivables to unaffiliated financial
institutions at a discount. In these factoring arrangements, for ease of administration, the Company collects customer payments related to the factored receivables and remits
those payments to the financial institutions. The Company sold $5,034 million and $4,508 million of trade accounts receivables under this program during the three months
ended March 28, 2025 and March 29, 2024, respectively. The costs of factoring such receivables were $24 million and $22 million for the three months ended March 28, 2025
and March 29, 2024, respectively. The cash received from the financial institutions is reflected within the operating activities section of our consolidated statement of cash
flows.
Our current capital allocation priorities are as follows: investing wisely to support our business operations, continuing to grow our dividend payment, enhancing our beverage
portfolio and capabilities through consumer-centric acquisitions, and using excess cash to repurchase shares over time. We currently expect 2025 capital expenditures to be
approximately $2.2 billion. During 2025, we expect to repurchase shares to offset dilution resulting from employee stock-based compensation.
We are currently in litigation with the IRS for tax years 2007 through 2009. On November 18, 2020, the Tax Court issued the Opinion in which it predominantly sided with the
IRS. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that certain U.S. tax regulations (known as the blocked-
income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the Company’s licensee in Brazil apply to the Company’s operations
and that the Tax Court opinion in 3M Co. & Subs. v. Commissioner (February 9, 2023) controlled as to the validity of those regulations. On August 2, 2024, the Tax Court
entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the total liability for the 2007 through
2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024. The Company paid the IRS Tax
Litigation Deposit on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through 2009 tax years. That amount, plus interest
earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three months ended March 28, 2025, the Company
recorded net interest income of $53 million related to this tax payment in the line item income taxes in our consolidated statement of income, in accordance with our accounting
policy. The payment of the IRS invoices and the related accrued interest were recorded in the line item other noncurrent assets in our consolidated balance sheets as of
March 28, 2025 and December 31, 2024. On October 22, 2024, the Company appealed the Tax Court’s decision to the U.S. Court of Appeals for the Eleventh Circuit. The
Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March 12, 2025. The Company strongly disagrees with the IRS’ positions
and the portions of the Opinions affirming such positions and intends to vigorously defend our positions utilizing every available avenue of appeal. While the Company
believes that it is more likely than not that we will ultimately prevail in this litigation upon appeal, it is possible that all, or some portion of, the adjustments proposed by the
IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or all of the $6.0 billion it paid
in response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $171 million as of March 28, 2025. Additionally, the Company would
likely be subject to significant additional liabilities for subsequent years, which could have a material adverse
37

-- 40 of 69 --

impact on the Company’s financial position, results of operations and cash flows. The Company estimates that the potential aggregate remaining incremental tax and interest
liability for the tax years 2010 through 2024 could be approximately $12 billion as of December 31, 2024. Additional income tax and interest on any unpaid potential liabilities
for the 2010 through 2024 tax years would continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The Company estimates the impact
of the continued application of the methodology asserted by the IRS and affirmed in the Opinions for the three months ended March 28, 2025 would increase the potential
aggregate incremental tax and interest liability by approximately $400 million. Refer to Note 9 of Notes to Consolidated Financial Statements for additional information on the
tax litigation.
While we believe it is more likely than not that we will prevail in the tax litigation discussed above, we are confident that, between our ability to generate cash flows from
operating activities and our ability to borrow funds at reasonable interest rates, we can manage the range of possible outcomes in the final resolution of the matter.
Based on all of the aforementioned factors, the Company believes its current liquidity position is strong and will continue to be sufficient to fund our operating activities and
cash commitments for investing and financing activities for the foreseeable future.
Cash Flows from Operating Activities
Net cash used in operating activities during the three months ended March 28, 2025 was $5,202 million, and net cash provided by operating activities during the three months
ended March 29, 2024 was $528 million, a decrease of $5,730 million. The decrease was primarily driven by $6,069 million of the $6,173 million final milestone payment for
fairlife that was made during the three months ended March 28, 2025, the prior year benefits of both the trade accounts receivable factoring program and the dividend payment
from an equity method investee in Thailand, as well as the unfavorable impact due to foreign currency exchange rate fluctuations. These items were partially offset by strong
cash operating results and the timing of changes in working capital.
Cash Flows from Investing Activities
Net cash used in investing activities during the three months ended March 28, 2025 was $1,067 million, and net cash provided by investing activities during the three months
ended March 29, 2024 was $330 million.
Purchases of Investments and Proceeds from Disposals of Investments
During the three months ended March 28, 2025, purchases of investments were $2,507 million and proceeds from disposals of investments were $1,005 million, resulting in a
net cash outflow of $1,502 million. During the three months ended March 29, 2024, purchases of investments were $2,552 million and proceeds from disposals of investments
were $444 million, resulting in a net cash outflow of $2,108 million. This activity primarily represents the purchases of, and proceeds from the disposals of, investments in
marketable securities and short-term investments that were made as part of the Company’s overall cash management strategy. Also included in this activity are purchases of,
and proceeds from the disposals of, investments held by our captive insurance companies. Refer to Note 4 of Notes to Consolidated Financial Statements for additional
information on our investments.
Proceeds from Disposals of Businesses, Equity Method Investments and Nonmarketable Securities
During the three months ended March 28, 2025 and March 29, 2024, proceeds from disposals of businesses, equity method investments and nonmarketable securities were
$748 million and $2,893 million, respectively. The activity during the three months ended March 28, 2025 primarily related to the sale of a portion of our ownership interest in
CCEP. The activity during the three months ended March 29, 2024 primarily related to sales of our ownership interests in certain equity method investees and the refranchising
of certain of our bottling operations. Refer to Note 2 of Notes to Consolidated Financial Statements.
Purchases of Property, Plant and Equipment
Purchases of property, plant and equipment during the three months ended March 28, 2025 and March 29, 2024 were $309 million and $370 million, respectively.
Cash Flows from Financing Activities
Net cash provided by financing activities during the three months ended March 28, 2025 and March 29, 2024 was $3,432 million and $406 million, respectively.
Loans, Notes Payable and Long-Term Debt
During the three months ended March 28, 2025, the Company had issuances of debt of $5,436 million, which consisted of $3,917 million of net issuances of commercial paper
and short-term debt with maturities of 90 days or less, $1,033 million of issuances of commercial paper and short-term debt with maturities greater than 90 days and long-term
debt issuances of
38

-- 41 of 69 --

$486 million, net of related discounts and issuance costs. Refer to Note 8 of Notes to Consolidated Financial Statements for additional information.
The Company made payments of debt of $1,599 million during the three months ended March 28, 2025, which consisted of $1,047 million of payments related to commercial
paper and short-term debt with maturities greater than 90 days and payments of long-term debt of $552 million.
During the three months ended March 29, 2024, the Company had issuances of debt of $2,285 million, which consisted of $2,221 million of issuances of commercial paper and
short-term debt with maturities greater than 90 days and long-term debt issuances of $64 million, net of related discounts and issuance costs.
The Company made payments of debt of $1,366 million during the three months ended March 29, 2024, which consisted of $369 million of net payments of commercial paper
and short-term debt with maturities of 90 days or less, payments of $408 million related to commercial paper and short-term debt with maturities greater than 90 days and
payments of long-term debt of $589 million.
Issuances of Stock
The issuances of stock during the three months ended March 28, 2025 and March 29, 2024 were related to the exercise of stock options by employees.
Purchases of Stock for Treasury
During the three months ended March 28, 2025, the total cash outflow for treasury stock purchases was $370 million. The Company repurchased 4.3 million shares of common
stock under the share repurchase plan authorized by our Board of Directors. These shares were repurchased at an average cost of $65.04 per share, for a total cost of $279
million. In addition to shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock
issued to employees. The net impact of the Company’s issuances of stock and share repurchases during the three months ended March 28, 2025 resulted in a net cash outflow of
$211 million.
During the three months ended March 29, 2024, the total cash outflow for treasury stock purchases was $702 million. The Company repurchased 10.4 million shares of
common stock under the share repurchase plan authorized by our Board of Directors. These shares were repurchased at an average cost of $60.04 per share, for a total cost of
$622 million. In addition to shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock
issued to employees. The net impact of the Company’s issuances of stock and share repurchases during the three months ended March 29, 2024 resulted in a net cash outflow of
$412 million.
Dividends
During the three months ended March 28, 2025 and March 29, 2024, the Company paid dividends of $89 million and $99 million, respectively. As a result of the timing of our
quarterly reporting periods as well as our dividend payment dates, the Company paid substantially all of the 2024 and 2025 first quarterly dividends in the second quarter of
each year.
Our Board of Directors approved the Company’s regular quarterly dividend of $0.51 per share at its May 2025 meeting. This dividend is payable on July 1, 2025 to
shareowners of record as of the close of business on June 13, 2025.
Other Financing Activities
During the three months ended March 28, 2025 and March 29, 2024, the total cash outflow for other financing activities was $105 million and $2 million, respectively. The
cash outflow during the three months ended March 28, 2025 included $104 million of the $6,173 million final milestone payment for fairlife.
Foreign Exchange
Our international operations are subject to certain opportunities and risks, including currency fluctuations and governmental actions. We closely monitor our operations in each
country and seek to adopt appropriate strategies that are responsive to changing economic and political environments as well as to fluctuations in currencies.
Due to the geographic diversity of our operations, weakness in some currencies may be offset by strength in other currencies over time. Our hedging activities are designed to
mitigate, over time, a portion of the potentially unfavorable impact of exchange rate fluctuations on our net income. Taking into account the effects of our hedging activities, the
impact of
39

-- 42 of 69 --

fluctuations in foreign currency exchange rates decreased our operating income for the three months ended March 28, 2025 by 18%.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have an unfavorable impact on operating income and
cash flows from operating activities through the end of the year.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We have no material changes to the disclosures on this matter made in our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the
effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as
amended (“Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded
that the Company’s disclosure controls and procedures were effective as of March 28, 2025.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting during the quarter ended March 28, 2025 that have materially affected, or are reasonably
likely to materially affect, the Company’s internal control over financial reporting.
40

-- 43 of 69 --

Part II. Other Information
Item 1. Legal Proceedings
Information regarding reportable legal proceedings is contained in Part I, “Item 3. Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31,
2024. The following updates and restates the description of the previously reported U.S. Federal Income Tax Dispute matter and describes a new environmental matter.
Management believes that, except as disclosed in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently
pending legal proceedings will not have a material adverse effect on the Company taken as a whole.
U.S. Federal Income Tax Dispute
On September 17, 2015, the Company received a Notice from the IRS seeking approximately $3.3 billion of additional federal income tax for years 2007 through 2009. In
the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from certain of its foreign affiliates that the U.S. parent company
licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in the Closing Agreement resolving that dispute. The Closing Agreement provided that, absent a change in material facts or circumstances or relevant federal tax law, in
calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax calculation methodology that
the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly
imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation,
preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the Tax Court in December 2015, challenging the tax adjustments enumerated in the Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued the Opinion in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid by the
foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would become
payable to the Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that
certain U.S. tax regulations (known as the blocked-income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the Company’s
licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v. Commissioner (February 9, 2023) controlled as to the validity of
those regulations.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that
41

-- 44 of 69 --

the retroactive imposition of such tax liability using a calculation methodology different from that previously agreed upon by the IRS and the Company, and audited by the IRS
for over a decade, is unconstitutional. The Company intends to assert its claims on appeal and vigorously defend its positions. In addition, for its litigation with the IRS and for
purposes of its appeal of the Tax Court decision, the Company continues to evaluate the implications of several significant administrative law cases recently decided by the U.S.
Supreme Court, most notably Loper Bright v. Raimondo, which overruled the Chevron case. Since 1984, the Chevron case had required that courts defer to agency
interpretations of statutes and agency action. In Ohio v. EPA and Garland v. Cargill, two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to rule on
agency interpretations and actions without the deference previously required by the Chevron case.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid the IRS Tax Litigation Deposit on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through 2009 tax years.
That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three months ended March 28,
2025, the Company recorded net interest income of $53 million related to this tax payment in the line item income taxes in our consolidated statement of income, in accordance
with our accounting policy. The payment of the IRS invoices and the related accrued interest were recorded in the line item other noncurrent assets in our consolidated balance
sheets as of March 28, 2025 and December 31, 2024. On October 22, 2024, the Company appealed the Tax Court’s decision to the U.S. Court of Appeals for the Eleventh
Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March 12, 2025.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors, and we reviewed and considered relevant laws, rules, and
regulations, including, but not limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-
founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not
the Company’s tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the Tax Court
Methodology, that could be applied by the courts upon final resolution of the litigation. Based on the required probability analysis, we determined the methodologies we believe
the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we recorded a tax reserve of $438 million during the year
ended December 31, 2020 related to the application of the resulting methodologies as well as the different tax treatment applicable to dividends originally paid to the U.S.
parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be recharacterized as royalties in accordance with the Opinions and the Company’s
analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of March 28, 2025. However,
based on the required probability analysis and the accrual of interest through the current reporting period, we updated our tax reserve as of March 28, 2025 to $483 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is possible that some portion or all of the
adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or
all of the $6.0 billion it paid in response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $171 million as of March 28, 2025.
Additionally, the Company would likely be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the Company’s
financial position, results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinions for the 2010 through 2024 tax years, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to
subsequent years, with consent of the federal courts. This impact would include taxes and interest accrued through December 31, 2024. The calculations incorporated the
estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the potential
aggregate remaining incremental tax and interest liability for the tax years 2010 through 2024 could be approximately $12 billion as of December 31, 2024. Additional income
tax and interest on any unpaid potential liabilities for the 2010 through 2024 tax years would continue to accrue until the time any such potential liability, or portion thereof,
were to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three months ended March 28, 2025 would increase the
potential aggregate incremental tax and interest liability by approximately $400 million. We currently project the continued application of the Tax Court Methodology in 2025,
assuming similar facts and circumstances as of December 31, 2024, would result in an incremental annual tax liability that would increase the Company’s effective tax rate by
approximately 3.5%.
42

-- 45 of 69 --

Environmental Matter
On April 11, 2025, the Commissioner of the Department of Licensing and Consumer Affairs and the Government of the United States Virgin Islands (“USVI”) filed a lawsuit
against the Company, CC One Virgin Islands as well as other unrelated parties in the Superior Court of the Virgin Islands, Division of St. Croix, concerning the environmental
impacts of plastic packaging in the USVI. The complaint asserts claims for (1) violations of USVI consumer protection statutes and (2) public nuisance. The complaint seeks
injunctive relief, restitution and civil penalties but does not specify an amount of damages sought. The Company believes it has strong defenses to the claims.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form
10-K for the year ended December 31, 2024, which could materially affect our business, financial condition or future results. The risks described in this report and in our
Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be
immaterial, could also materially adversely affect our business, financial condition or future results.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended March 28, 2025 by the Company or
any “affiliated purchaser” of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:
Period
Total Number of Shares
Purchased
Average
Price Paid
Per Share
Total Number of
Shares Purchased as Part of the
Publicly
Announced Plan
Maximum Number
of Shares That May
Yet Be Purchased
Under the Publicly
Announced Plan
January 1, 2025 through January 24, 2025 	1,665,513 $ 	61.73 	1,665,266 	74,684,713
January 25, 2025 through February 21, 2025 	3,045,474 	66.80 	1,766,420 	72,918,293
February 22, 2025 through March 28, 2025 	911,298 	70.80 	860,259 	72,058,034
Total 	5,622,285 $ 	65.95 	4,291,945
The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the 2019 Plan described in footnote 2 below and (2) shares surrendered, if any, to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.
In February 2019, the Company publicly announced that our Board of Directors had authorized a plan (“2019 Plan”) for the Company to purchase up to 150 million shares of our common stock.
This column discloses the number of shares purchased, if any, pursuant to the 2019 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading
plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
Item 5. Other Information
During the fiscal quarter ended March 28, 2025, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as follows:
Bruno Pietracci, President, Latin America operating unit, adopted a Rule 10b5-1 trading arrangement on March 5, 2025 for the potential exercise of vested stock options and the
associated sale of up to 75,727 shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is March 5, 2027, or such earlier date
upon which all transactions are completed.
James Quincey, Chairman of the Board of Directors and Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement on February 28, 2025 for the potential exercise of
vested stock options and the associated sale of up to 604,227 shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is
February 8, 2027, or such earlier date upon which all transactions are completed.
These trading plans were adopted during an open trading window.
Item 6. Exhibits
In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to
provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations, warranties, covenants
and conditions
1 	2
1
2
43

-- 46 of 69 --

by or of each of the parties to the applicable agreement. These representations, warranties, covenants and conditions have been made solely for the benefit of the other parties to
the applicable agreement and:
• should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be
inaccurate;
• may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not
necessarily reflected in the agreement;
• may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
• were made only as of the date of the applicable agreement, or such other date or dates as may be specified in the agreement, and are subject to more recent developments.
Accordingly, these representations, warranties, covenants and conditions may not describe the actual state of affairs as of the date they were made or at any other time.
Additional information about the Company may be found elsewhere in this report and the Company’s other public filings, which are available without charge through the
Securities and Exchange Commission’s website at http://www.sec.gov.
EXHIBIT INDEX
Exhibit No.
(With regard to applicable cross-references in the list of exhibits below, the Company’s Current, Quarterly and Annual Reports are filed with the Securities and Exchange
Commission (“SEC”) under File No. 001-02217; and Coca-Cola Refreshments USA, LLC’s (formerly known as Coca-Cola Refreshments USA, Inc. and Coca-Cola
Enterprises Inc.) Current, Quarterly and Annual Reports are filed with the SEC under File No. 001-09300).
3.1 	Certificate of Incorporation of the Company, including Amendment of Certificate of Incorporation, dated July 27, 2012 — incorporated herein by reference to
Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2012.
3.2 	By-Laws of the Company, as amended and restated through October 19, 2023 — incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report
on Form 8-K filed on October 20, 2023.
4.1 	As permitted by the rules of the SEC, the Company has not filed certain instruments defining the rights of holders of long-term debt of the Company or
consolidated subsidiaries under which the total amount of securities authorized does not exceed 10% of the total assets of the Company and its consolidated
subsidiaries. The Company agrees to furnish to the SEC, upon request, a copy of any omitted instrument.
4.2 	Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust
Company, as trustee — incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.3 	First Supplemental Indenture, dated as of February 24, 1992, to Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche
Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.2 to the Company’s Current
Report on
Form 8-K filed on May 25, 2017.
4.4 	Second Supplemental Indenture, dated as of November 1, 2007, to Amended and Restated Indenture, dated as of April 26, 1988, as amended, between the
Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.3 to
the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.5 	Form of Note for 1.875% Notes due 2026 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 19, 2014.
4.6 	Form of Note for 1.125% Notes due 2027 — incorporated herein by reference to Exhibit 4.7 to the Company’s Registration Statement on Form 8-A filed on March
6, 2015.
4.7 	Form of Note for 1.625% Notes due 2035 — incorporated herein by reference to Exhibit 4.8 to the Company’s Registration Statement on Form 8-A filed on March
6, 2015.
4.8 	Form of Note for 1.100% Notes due 2036 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 2, 2016.
4.9 	Form of Note for 2.900% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 25,
2017.
4.10 	Form of Note for 0.750% Notes due 2026 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 8,
2019.
4.11 	Form of Note for 1.250% Notes due 2031 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 8,
2019.
4.12 	Form of Note for 2.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September 9,
2019.
44

-- 47 of 69 --

4.13 	Form of Note for 3.375% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.14 	Form of Note for 3.450% Notes due 2030 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.15 	Form of Note for 4.125% Notes due 2040 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.16 	Form of Note for 4.200% Notes due 2050 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.17 	Form of Note for 1.450% Notes due 2027 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.18 	Form of Note for 1.650% Notes due 2030 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.19 	Form of Note for 2.500% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.20 	Form of Note for 2.600% Notes due 2050 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.21 	Form of Note for 2.750% Notes due 2060 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.22 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.23 	Form of Note for 0.375% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.24 	Form of Note for 0.800% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.25 	Form of Note for 1.000% Notes due 2028 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.26 	Form of Note for 1.375% Notes due 2031 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.27 	Form of Note for 2.500% Notes due 2051 — incorporated herein by reference to Exhibit 4.9 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.28 	Form of Note for 1.500% Notes due 2028 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.29 	Form of Note for 2.000% Notes due 2031 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.30 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.31 	Form of Note for 0.500% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.32 	Form of Note for 1.000% Notes due 2041 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.33 	Form of Note for 2.250% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.34 	Form of Note for 2.875% Notes due 2041 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.35 	Form of Note for 3.000% Notes due 2051 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.36 	Form of Note for 0.950% Notes due 2036 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 6, 2021.
4.37 	Form of Note for 0.400% Notes due 2030 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 17,
2021.
4.38 	Form of Note for 5.000% Notes due 2034 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.39 	Form of Note for 5.300% Notes due 2054 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.40 	Form of Note for 5.400% Notes due 2064 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
45

-- 48 of 69 --

4.41 	Form of Note for 3.125% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 14,
2024.
4.42 	Form of Note for 3.500% Notes due 2044 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 14,
2024.
4.43 	Form of Note for 4.650% Notes due 2034 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on August 14,
2024.
4.44 	Form of Note for 5.200% Notes due 2055 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on August 14,
2024.
4.45 	Form of Note for 3.375% Notes due 2037 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on August 15,
2024.
4.46 	Form of Note for 3.750% Notes due 2053 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on August 15,
2024.
4.47 	Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche Bank Trust Company Americas, as trustee — incorporated herein
by reference to Exhibit 4.1 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-K dated July 30, 1991.
4.48 	First Supplemental Indenture, dated as of January 29, 1992, to the Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche
Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.01 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-
K dated January 29, 1992.
4.49 	Second Supplemental Indenture, dated as of June 22, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc.,
the Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on
Form 8-K filed on June 23, 2017.
4.50 	Third Supplemental Indenture, dated as of July 5, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc., the
Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-
K filed on July 6, 2017.
10.1 	The Coca-Cola Company Severance Pay Plan, as amended and restated effective January 1, 2025.
31.1 	Rule 13a-14(a)/15d-14(a) Certification, executed by James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company.
31.2 	Rule 13a-14(a)/15d-14(a) Certification, executed by John Murphy, President and Chief Financial Officer of The Coca-Cola Company.
32.1 	Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350),
executed by James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company, and by John Murphy, President and
Chief Financial Officer of The Coca-Cola Company.
101 	The following financial information from The Coca-Cola Company’s Quarterly Report on Form 10-Q for the quarter ended March 28, 2025, formatted in iXBRL
(Inline Extensible Business Reporting Language): (i) Consolidated Statements of Income for the three months ended March 28, 2025 and March 29, 2024; (ii)
Consolidated Statements of Comprehensive Income for the three months ended March 28, 2025 and March 29, 2024; (iii) Consolidated Balance Sheets as of
March 28, 2025 and December 31, 2024; (iv) Consolidated Statements of Cash Flows for the three months ended March 28, 2025 and March 29, 2024; and (v)
Notes to Consolidated Financial Statements.
104 	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the iXBRL document and included in Exhibit 101).
46

-- 49 of 69 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
THE COCA-COLA COMPANY
(Registrant)
/s/ ERIN L. MAY
Date: 	May 1, 2025 	Erin L. May
Senior Vice President, Controller and Chief Accounting Officer
(Principal Accounting Officer)
47

-- 50 of 69 --

Exhibit 10.1
THE COCA-COLA COMPANY
SEVERANCE PAY PLAN
AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2025

-- 51 of 69 --

ARTICLE 1
PURPOSE AND ADOPTION OF PLAN
The Coca-Cola Company established The Coca-Cola Company Severance Pay Plan (the "Plan") effective as of January 1, 1993 to provide
benefits to certain eligible employees of the Company who were terminated by the Company. The Plan has been amended and restated
periodically. The Company now amends and restates the Plan effective January 1, 2025. The Plan shall be an unfunded severance pay plan that is a
welfare plan as such term is defined by the Employee Retirement Income Security Act of 1974, as amended, ("ERISA"), the benefits of which
shall be paid solely from the general assets of the Company.
The Plan, as amended and restated, is applicable to employees whose employment is terminated on or after January 1, 2025.
ARTICLE 2
DEFINITIONS
For purposes of this Plan, the following terms shall have the meanings set forth below.
Administrator means the individual(s) designated by the Committee to make certain determinations with regard to benefit payable under
Article 3 and claims under Article 5 of this Plan.
Affiliate means any corporation or other business organization in which the Company owns, directly or indirectly, 20% or more of the
voting stock or capital at the relevant time.
Approved Leave of Absence means an approved military leave of absence or leave of absence under the Family and Medical Leave Act.
Cause means a violation of the Company's Code of Business Conduct or any other policy of the Company or an Affiliate, or gross
misconduct, all as determined by the Administrator, in its sole discretion.
Committee means The Coca-Cola Company Benefits Committee appointed by the Senior Vice President, Chief People Officer (or the
most senior human resources officer of the Company), which shall act on behalf of the Company to administer the Plan as provided in Article 4.
Company means The Coca-Cola Company.
Comparable Position means a position in the Company or with an Affiliate, or a position with an entity to whom all or any part of a
Company division, subsidiary, or other business segment is outsourced, sold, or otherwise disposed (including, without limitation, a disposition by
sale of shares of stock or of assets) that, at the time the employment offer is made:
(a) except in the case of a Global Mobility Assignee, provides a principal place of employment of not more than 50 miles from the last
principal place of employment with the Company or an Affiliate, and

-- 52 of 69 --

(b) provides a base salary (or hourly wage, if applicable) that is at least equal to the base salary (or hourly wage, if applicable) of the
current position.
Notwithstanding the preceding sentence, a Temporary Assignment, as defined in Section 3.1(b) shall not be considered a Comparable
Position.
Disability or Disabled means a condition for which a Participant becomes eligible for and receives a disability benefit under the long-term
disability insurance policy issued to the Company providing Basic Long Term Disability Insurance benefits pursuant to The Coca-Cola Company
Health and Welfare Benefits Plan, or under any other long-term disability plan that hereafter may be maintained by the Company or any Affiliate.
Global Mobility Assignee means an employee of the Company or any Affiliate who is classified as a Global Mobility Assignee in the
Company's personnel and payroll systems.
Participant means:
(a) a regular full-time or regular part-time (working at least 30 hours per week) employee of the Company or a Participating Affiliate who
works primarily within the United States (one of the fifty states or the District of Columbia) and who is actively at work or on an Approved
Leave of Absence, or
(b) a regular, full-time salaried Global Mobility Assignee who is actively at work or on an Approved Leave of Absence.
Notwithstanding the foregoing, the term “Participant” shall not include any employee covered by a collective bargaining agreement
between an employee representative and the Company or any Affiliate, unless the collective bargaining agreement provides for the employee's
participation in this Plan.
An individual shall be treated as an “employee” for purposes of this Plan for any period only if (i) he or she is actually classified during
such period by the Company (or to the extent applicable, any Affiliate) on its payroll, personnel and benefits system as an employee, and (ii) he or
she is paid for services rendered during such period through the payroll system, as distinguished from the accounts payable department, of the
Company or the Affiliate. No other individual shall be treated as an employee under this Plan for any period, regardless of his or her status during
such period as an employee under common law or under any statute. In addition, an individual shall be treated as an exempt or nonexempt
employee for purposes of this Plan only if he or she is actually classified during such period by the Company or an Affiliate on its payroll,
personnel and benefits system as an exempt or nonexempt employee.
Participating Affiliate means any Affiliate that the Committee has designated as such, as set forth in Appendix A.
Plan means The Coca-Cola Company Severance Pay Plan.
Qualifying Event means an involuntary loss of employment for reasons other than poor performance or Cause. A Qualifying Event shall
not, however, include a seasonal layoff or voluntary reduction in hours.

-- 53 of 69 --

Subsidiary means any corporation, limited liability company, partnership or other entity, of which 50% or more of the outstanding voting
stock or voting power is beneficially owned directly or indirectly by the Company.
System Employer means:
(a) an Affiliate,
(b) any entity that has an ongoing contractual relationship with the Company or a Subsidiary that provides such entity the rights to
manufacture, prepare, package, and/or distribute, and sell to customers or consumers beverages/brands for which the trademark is owned
by the Company or a Subsidiary, or
(c) an entity that is approved by the Committee as a System Employer based on its relationship with the Company or its Subsidiaries.
Weekly Pay means:
(a) 	For a Participant whose pay is based on a base salary, "Weekly Pay" means 1/52 of a Participant's annual base salary (as determined
by the Committee) as in effect on the date the Committee determines that his or her active employment terminated.
(b) For a Participant whose pay is based on an hourly rate, "Weekly Pay" means that individual's hourly rate multiplied by the lesser of
(i) 40 or (ii) the number of hours per week the individual ordinarily was expected to work immediately before his or her termination of
employment, as determined by the Committee.
(c) For a Participant whose pay is based on a daily rate, "Weekly Pay" means the amount used to calculate his or her hourly paid time off
rate (e.g., pay for one hour of vacation) multiplied by the lesser of (i) 40 or (ii) the number of hours per week the individual ordinarily was
expected to work immediately before his or her termination of employment, as determined by the Committee.
(d) For a Participant whose pay depends, at least in part, on commissions, "Weekly Pay" shall mean his or her basic weekly pay rate (as
determined under subparagraph (a) above), plus the weekly average commission he or she earned during the calendar year immediately
preceding the calendar year in which his or her active employment terminates (or, if not employed during the prior year, in the year of
termination).
(e) The Weekly Pay of a Participant shall not include amounts being paid to the individual as a cost-of-living adjustment (COLA) or cost-
of-relocation adjustment (CORA).
(f) The Committee may, from time to time, establish procedures consistent with the provisions of subparagraphs (a) through (e) of this
definition for determining the "Weekly Pay" of Participants.

-- 54 of 69 --

Years of Service means:
(a) For Participants hired or rehired by the Company or a Participating Affiliate on or after May 1, 2024:
(1) the Participant's full years of employment beginning on the Participant’s most recent hire or rehire date at the Company or any
Participating Affiliate, as determined by the Committee based on the Company's or Participating Affiliate's personnel records; and
(2) if the Participant transfers directly from a System Employer to the Company or a Participating Affiliate, such that his or her
termination with the System Employer and his or her hire or rehire date with the Company or a Participating Affiliate are continuous
except due to a non-business day or days, the Participant’s full and continuous whole years of employment as an employee of the
System Employer shall be added to the period described in provision (1); and
(3) if the Participant described in provision (2) transferred directly to the System Employer from the Company or a Participating
Affiliate, such that his or her termination with the Company or a Participating Affiliate and his or her hire or rehire date with the
System Employer are continuous except due to a non-business day or days, the Participant’s prior full and continuous whole years of
employment as an employee of the Company or a Participating Affiliate shall be added to the period described in provisions (1) and
(2).
(b) For Participants hired or rehired by the Company or a Participating Affiliate prior to May 1, 2024:
(1) for each Participant who is a Global Mobility Assignee, the Participant's full and continuous whole years of employment as a
part-time, regular, hourly, or salaried employee of the Company or any Affiliate, as determined by the Committee based on the
Company's or Affiliate's personnel records; and
(2) for each other Participant, the Participant's whole Years of Vesting Service, as defined in the qualified pension plan in which the
Participant participates.
(c) Notwithstanding paragraphs (a) and (b), "Years of Service" shall not include any period of employment with the Company or any
System Employer for which the Participant is receiving or previously has received any severance pay or similar benefits, whether under
this Plan or any other plan or arrangement sponsored or paid by the Company or any System Employer.
ARTICLE 3
BENEFITS
3.1 Circumstances in Which Benefits are Payable.
(a) 	Qualifying Event. A Participant shall qualify for a benefit under Section 3.3(a) of this Plan as a result of his or her involuntary loss of
employment with the Company, a

-- 55 of 69 --

Participating Affiliate, or, solely with respect to a Global Mobility Assignee, an Affiliate, if the Administrator in its discretion determines
that:
(1) his or her employment terminated as a result of a Qualifying Event;
(2) his or her termination was unrelated to a sale or other disposition, including outsourcing, of all or any part of a division,
subsidiary or other business segment (including, without limitation, a disposition by sale of shares of stock or of assets) in which he or
she was employed, unless he or she was not offered a Comparable Position with the purchaser, acquirer or outsource vendor of the
division, subsidiary or business segment; and
(3) he or she properly, timely and unconditionally executes and does not revoke, the release and, if applicable, an agreement on
confidentiality and competition required under Section 3.l(d).
(b) Temporary Assignments. A Participant filling a temporary role for 18 months or less (“Temporary Assignment”) shall qualify for a
benefit under Section 3.3(a) of this Plan as a result of an involuntary loss of his or her pre-Temporary Assignment position with the
Company or a Participating Affiliate upon the conclusion of his or her Temporary Assignment. Even if a Participant experiences
consecutive Temporary Assignments, the involuntary loss of employment shall only relate to his or her pre-Temporary Assignment
position. A Participant on Temporary Assignment shall only qualify under this Section 3.1(b) if he or she has been designated as
performing a Temporary Assignment on the Company’s (or Participating Affiliate’s, as applicable) personnel records.
(c) 	Other Involuntary Terminations. A Participant who fails to satisfy the requirements of Section 3.1(a) or (b) nevertheless shall qualify
for a benefit as a result of his or her involuntary loss of employment with the Company, a Participating Affiliate, or, solely with respect to a
Global Mobility Assignee, an Affiliate, if:
(1) his or her employment was not terminated for Cause; and
(2) he or she properly, timely and unconditionally executes, and does not revoke, the release and, if applicable, an agreement on
confidentiality and competition required under Section 3.l(d).
The benefit payable under this Section 3.l(c) shall equal the Participant's Weekly Pay multiplied by eight.
(d) Release, Noncompetition and Nondisclosure Form. Participants shall be provided with releases and agreements on confidentiality and
competition that Participants shall be required to properly, timely and unconditionally execute as a condition to qualifying for a benefit
under this Plan, and such documents shall set forth the minimum requirements for a release and an agreement on confidentiality and
competition under this Plan. The Administrator, as part of each determination under Section 3.1, also shall determine whether the release
for a Participant shall (for reasons sufficient to the Administrator) include requirements in addition to the minimum requirements set forth
in the form and shall revise the form release for such Participant accordingly. The Administrator in its sole discretion

-- 56 of 69 --

shall (for reasons sufficient to the Administrator) determine whether a Participant is required also to sign an agreement on confidentiality
and competition to qualify for a benefit under this Plan. The Administrator also shall determine whether the agreements shall contain
additional requirements such as, but not limited to, a non-solicitation agreement and a non-disparagement agreement. If a Participant
declines to properly, timely and unconditionally execute the release and, if applicable, an agreement on confidentiality and competition
required by the Administrator for the benefit described in Section 3.l(a), (b), or (c), the Participant shall not qualify for any benefit under
this Plan.
3.2 Circumstances in Which Benefits are Not Payable.
Notwithstanding any other provision in this Plan to the contrary, an employee is not entitled to benefits under this Plan if the employee:
(a) voluntarily terminates employment,
(b) was Disabled or on a leave of absence (except for an Approved Leave of Absence) immediately prior to his or her termination of
employment,
(c) prior to receiving any benefit under the Plan, is offered a Comparable Position, as determined by the Administrator, with the
Company or one of its Affiliates,
(d) is offered a Comparable Position, as determined by the Administrator, in connection with the sale or other disposition, including
outsourcing, of all or any part of a division, subsidiary or other business segment (including, without limitation, a disposition by sale of
shares of stock or of assets) in which he or she was employed,
(e) is terminated for Cause, as determined by the Administrator,
(f) is receiving pension benefits while a Participant from a qualified defined benefit pension plan sponsored by the Company or an
Affiliate, or
(g) waived participation in the Plan through any means, receives severance pay under another severance plan of the Company or an
Affiliate or has entered into an individual employment or severance agreement with the Company or an Affiliate that provides for
severance benefits and such agreement is in effect on the date of the Participant's termination of employment, even if such severance
benefits would be less than that offered under the Plan.

-- 57 of 69 --

3.3 Benefit Formula.
(a) 	Unless a Participant is described in Section 3.3(b) below, if a Participant qualifies under Section 3.l(a) (Qualifying Event) or Section
3.1(b) (Temporary Assignments) for a benefit, his or her benefit under this Plan shall equal his or her Weekly Pay multiplied by the
designated number of weeks determined by his or her Years of Service, subject to any minimum or maximum, set forth below. A
Participant shall be assigned to a benefit opposite his or her job grade (as determined from the Company's or Participating Affiliate's
payroll records as of the date his or her employment terminated) and, if applicable, his or her status as an elected corporate officer of the
Company as of the date his or her employment terminated, under this Section 3.3(a):
Career Group 	Benefit Level Per Year of
Service
Minimum 	Maximum
Executive Leadership
Team
N/A 	104 weeks 	104 weeks
E 	4 weeks 	32 weeks 	78 weeks
D 	4 weeks 	32 weeks 	52 weeks
C 	3 weeks 	12 weeks 	52 weeks
A, B 	2 weeks 	9 weeks 	52 weeks
Hourly 	1 week 	8 weeks 	26 weeks

-- 58 of 69 --

(b) If a regular full-time nonexempt employee qualifies under Section 3.1(a) (Qualifying Event) for a benefit and works at a facility listed
on Appendix B, such benefit under this Plan shall equal the Participant's Weekly Pay multiplied by the service factor set forth in the
following table:
Years of Service 	Service Factor
Less than 8 years 	8 weeks
8 years but less than 9 years 	9 weeks
9 years but less than 10 years 	10 weeks
10 years but less than 11 years 	11 weeks
11 years but less than 12 years 	12 weeks
12 years but less than 13 years 	13 weeks
13 years but less than 14 years 	14 weeks
14 years but less than 15 years 	15 weeks
15 years but less than 16 years 	16 weeks
16 years but less than 17 years 	18 weeks
17 years but less than 18 years 	20 weeks
18 years but less than 19 years 	22 weeks
19 years but less than 20 years 	24 weeks
20 years or more 	26 weeks
3.4 Benefit Payment Timing. If a Participant qualifies for a benefit under this Plan, such benefit shall be paid as soon as
practicable after his or her active employment has terminated, and payment shall be made in a lump sum. In no event shall a benefit under this
Plan be paid after March 15 of the year following the year of Participant's termination of employment. No interest whatsoever shall be paid on
any benefit under this Plan.
3.5 Withholding. The Company shall have the right to take such action as it deems necessary or appropriate in order to satisfy
any federal, state or local income or other tax requirement to withhold or make deductions from any benefit otherwise payable under this Plan.
th

-- 59 of 69 --

3.6 Forfeiture of Benefit.
(a) 	Ineligible for Payment or Payment in Error. If the Administrator determines that the Participant is ineligible for a benefit due to
continuous employment by a System Employer after termination with the Company or a Participating Affiliate, or that a determination was
made in error, the benefit shall be forfeited and/or returned to the Company, as applicable. The Administrator has the sole discretion to
determine on a case-by-case basis any benefit or benefit payment that will be forfeited and/or returned to the Company.
(b) Violation of Code of Business Conduct or Company Policy. If, following the determination that a Participant is entitled to a benefit
under the Plan, the Administrator determines that during the Participant's employment, the Participant violated the Company's Code of
Business Conduct or any other policy of the Company or Participating Affiliate, all or a portion of the Participant's benefit under the Plan
may cease or be forfeited. The Administrator has the sole discretion to determine on a case-by-case basis any benefit or benefit payment
that will be forfeited and/or returned to the Company.
(c) 	Disability. If, following the determination that a Participant is entitled to a benefit under the Plan, the Participant becomes Disabled,
his or her benefit under the Plan shall cease or be forfeited and any benefit paid must be repaid to the Company or Participating Affiliate.
3.8 No Duplication of Benefits. If the Administrator determines that the benefit payable under this Plan to a Participant duplicates
(directly or indirectly) any other benefit otherwise payable to such Participant by the Company or any Affiliate (including, without limitation, any
repatriation payment or allowance or any termination indemnity), the Administrator shall have the right to reduce the benefit otherwise payable
under this Plan to the extent deemed necessary to eliminate such duplication.
ARTICLE 4
ADMINISTRATION
4.1 Committee.
(a) The Committee shall be responsible for the general administration of the Plan. As such, the Committee is the "Plan Administrator"
and a "named fiduciary" of the Plan (as those terms are used in ERISA). In the absence of the appointment of a Committee, the functions
and powers of the Committee shall reside with the Company. The Committee, in the exercise of its authority, shall discharge its duties with
respect to the Plan in accordance with ERISA and corresponding regulations, as amended from time to time.
(b) The Committee shall establish regulations for the day-to-day administration of the Plan. The Committee and its designated agents
shall have the exclusive right and discretion to interpret the terms and conditions of the Plan and to decide all matters arising with respect
to the Plan's administration and operation (including factual issues). Any interpretations or decisions so made shall be conclusive and
binding on all persons. The Committee or its designee may pay the expenses of administering the Plan or may reimburse the Company or
other person performing administrative services with respect to the Plan if the Company or such other person directly pays such expenses
at the request of the Committee.

-- 60 of 69 --

4.2 Authority to Appoint Advisors and Agents. The Committee may appoint, designate and employ such persons as it may deem
advisable and as it may require in carrying out the provisions of the Plan. To the extent permitted by law, the members of the Committee and the
Administrator shall be fully protected by any action taken in reliance upon advice given by such persons and in reliance on tables, valuations,
certificates, determinations, opinions and reports that are furnished by any accountant, counsel, claims administrator or other expert who is
employed or engaged by the Committee.
4.3 Compensation and Expenses of Committee. The members of the Committee shall receive no compensation for its duties hereunder,
but the Committee shall be reimbursed for all reasonable and necessary expenses incurred in the performance of its duties, including counsel fees
and expenses. Such expenses of the Committee, including the compensation of administrators, actuaries, counsel, agents or others that the
Committee may employ, shall be paid out of the general assets of the Company.
4.4 Records. The Committee shall keep or cause to be kept books and records with respect to the operations and administration of this
Plan.
4.5 Indemnification of Committee. The Company agrees to indemnify and to defend to the fullest extent permitted by law any employee
serving as a member of the Committee and the Administrator or as their delegate(s) against all liabilities, damages, costs and expenses, including
attorneys' fees and amounts paid in settlement of any claims approved by the Company, occasioned by any act or failure to act in connection with
the Plan, unless such act or omission arises out of such employee's gross negligence, willful neglect or willful misconduct.
4.6 Fiduciary Responsibility Insurance, Bonding. If the Company has not done so, the Committee may purchase appropriate insurance on
behalf of the Plan and the Plan's fiduciaries to cover liability or losses occurring by reason of the acts or omissions of a fiduciary; provided,
however, that such insurance to the extent purchased by the Plan must permit recourse by the insurer against the fiduciary in the case of a breach
of a fiduciary duty or obligation by such fiduciary. The cost of such insurance shall be paid out of the general assets of the Company. The
Committee may also obtain a bond covering all the Plan's fiduciaries, to be paid from the general assets of the Company.
ARTICLE 5
CLAIMS PROCEDURE
5.1 Right to File a Claim. Any Participant who believes he or she is entitled to a benefit hereunder that has not been received, may file a
claim in writing with the Administrator. The claim must be filed within six months after the date of the Participant's termination of active
employment. The Administrator may require such claimant to submit additional documentation, if necessary, in support of the initial claim.
5.2 Denial of a Claim. Any claimant whose claim to any benefit hereunder has been denied in whole or in part shall receive a notice from
the Administrator within 90 days of such filing or within 180 days after such receipt if special circumstances require an extension of time. If the
Administrator determines that an extension of time is required, the claimant will be notified in writing of the extension and reason for the
extension within 90 days after the Administrator's receipt of the claim. The extension notice will also include the date by which the Administrator
expects to

-- 61 of 69 --

make the benefit determination. The notice of the denial of the claim will set forth the specific reasons for such denial, specific references to the
Plan provisions on which the denial was based and an explanation of the procedure for review of the denial.
5.3 Claim Review Procedure. A claimant may appeal the denial of a claim to the Committee by written request for review to be made
within 60 days after receiving notice of the denial. The request for review shall set forth all grounds on which it is based, together with supporting
facts and evidence that the claimant deems pertinent, and the Committee shall give the claimant the opportunity to review pertinent Plan
documents in preparing the request. The Committee may require the claimant to submit such additional facts, documents, or other material as it
deems necessary or advisable in making its review. The Committee will provide the claimant a written or electronic notice of the decision within
60 days after receipt of the request for review, except that, if there are special circumstances requiring an extension of time for processing, the 60-
day period may be extended for an additional 60 days. If the Committee determines that an extension of time is required, the claimant will be
notified in writing of the extension and reason for the extension within 60 days after the Committee's receipt of the request for review. The
extension notice will also include the date by which the Committee expects to complete the review. The Committee shall communicate to the
claimant in writing its decision, and if the Committee confirms the denial, in whole or in part, the communication shall set forth the reasons for the
decision and specific references to the Plan provisions on which the decision is based.
5.4 Limitation on Actions. Any suit for benefits must be brought within one year after the date the Committee (or its designee) has made
a final denial (or deemed denial) of the claim. Notwithstanding any other provision herein, any suit for benefits must be brought within two years
of the date of termination of active employment. No claimant may file suit for benefits until exhausting the claim review procedure described
herein. All suits must be brought in the U.S. District Court for the Northern District of Georgia in Atlanta, Georgia in accordance with Section 7.7.
ARTICLE 6
AMENDMENT AND TERMINATION OF PLAN
6.1 Amendment of Plan. The Committee reserves the right to amend the provisions of the Plan at any time to any extent and in any
manner it desires by execution of a written document describing the intended amendment(s).
6.2 Termination of Plan. The Company shall have no obligation whatsoever to maintain the Plan or any benefit under the Plan for any
given length of time. The Company reserves the right to terminate the Plan or any benefit option under the Plan at any time by written document.
ARTICLE 7 MISCELLANEOUS PROVISIONS
7.1 Plan Is Not an Employment Contract. This Plan is not a contract of employment, and neither the Plan nor the payment of any benefits
will be construed as giving to any person any legal or equitable right to employment by the Company or any Affiliate. Nothing herein shall be

-- 62 of 69 --

construed to interfere with the right of the Company of any Affiliate to discharge, with or without cause, any employee at any time.
7.2 Assignment. A Participant may not assign or alienate any payment with respect to any benefit that a Participant is entitled to receive
from the Plan, and further, except as may be prescribed by law, no benefits shall be subject to attachment or garnishment of or for a Participant's
debts or contracts, except for recovery of overpayments made on a Participant's behalf by this Plan.
7.3 Fraud. No payments with respect to benefits under this Plan will be paid if the Participant attempts to perpetrate a fraud upon the Plan
with respect to any such claim. The Committee shall have the right to make the final determination of whether a fraud has been attempted or
committed upon the Plan or if a misrepresentation of fact has been made, and its decision shall be final, conclusive and binding upon all persons.
The Plan shall have the right to fully recover any amounts, with interest, improperly paid by the Plan by reason of fraud, attempted fraud, or
misrepresentation of fact by a Participant and to pursue all other legal or equitable remedies.
7.4 Offset for Monies Owed. The benefits provided hereunder will be offset for any monies that the Committee determines are owed to
the Company or any Affiliate.
7.5 Funding Status of Plan. The benefits provided hereunder will be paid solely from the general assets of the Company, and nothing
herein will be construed to require the Company or the Committee to maintain any fund or segregate any amount for the benefit of any Participant.
No Participant or other person shall have any claim against, right to, or security or other interest in, any fund, account, or asset of the Company
from which any payment under the Plan may be made.
7.6 Construction. This Plan shall be construed, administered, and enforced according to the laws of the State of Delaware, except to the
extent preempted by federal law. The headings and subheadings are set forth for convenient reference only and have no substantive effect
whatsoever. All pronouns and all variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural, as the identity of
the person, persons or entity may require.
7.7 Restriction of Venue. Any legal action in connection with the Plan by an employee, Participant, or other interested party shall only be
brought in the U.S. District Court for the Northern District of Georgia in Atlanta, Georgia.
7.8 Conclusiveness of Records. The records of the Company with respect to age, employment history, compensation, and all other
relevant matters shall be conclusive for purposes of the administration of, and the resolution of claims arising under, the Plan.

-- 63 of 69 --

The Committee has caused this amended and restated Plan to be signed by its duly authorized member, effective as of January 1, 2025.
THE COCA-COLA COMPANY BENEFITS COMMITTEE
By: /s/Silvina Kippke
Chairperson

-- 64 of 69 --

APPENDIX A
Participating Affiliates
Coca-Cola Properties, LLC International Auditors, Inc. Red Tree
Beverages, LLC
BA Sports Nutrition, LLC

-- 65 of 69 --

APPENDIX B
Section 3.3(b) Facility
Portland Syrup Plant (OR)

-- 66 of 69 --

Exhibit 31.1
CERTIFICATIONS
I, James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter
(the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	May 1, 2025
/s/ James Quincey
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of
The Coca-Cola Company

-- 67 of 69 --

Exhibit 31.2
CERTIFICATIONS
I, John Murphy, President and Chief Financial Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter
(the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	May 1, 2025
/s/ John Murphy
John Murphy
President and Chief Financial Officer of The Coca-Cola Company

-- 68 of 69 --

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of The Coca-Cola Company (“Company”) on Form 10-Q for the period ended March 28, 2025 (“Report”), I, James Quincey, Chairman
of the Board of Directors and Chief Executive Officer of the Company and I, John Murphy, President and Chief Financial Officer of the Company, each certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) 	to my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ JAMES QUINCEY
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company
May 1, 2025
/s/ JOHN MURPHY
John Murphy
President and Chief Financial Officer of The Coca-Cola Company
May 1, 2025

-- 69 of 69 --